WO2023094303A1 - Microbiocidal heterobiaryl amide derivatives - Google Patents

Microbiocidal heterobiaryl amide derivatives Download PDF

Info

Publication number
WO2023094303A1
WO2023094303A1 PCT/EP2022/082566 EP2022082566W WO2023094303A1 WO 2023094303 A1 WO2023094303 A1 WO 2023094303A1 EP 2022082566 W EP2022082566 W EP 2022082566W WO 2023094303 A1 WO2023094303 A1 WO 2023094303A1
Authority
WO
WIPO (PCT)
Prior art keywords
methyl
pyridyl
phenyl
compounds
formula
Prior art date
Application number
PCT/EP2022/082566
Other languages
French (fr)
Inventor
Andrew Edmunds
Nicolas Germain
Thomas James Hoffman
Original Assignee
Syngenta Crop Protection Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Crop Protection Ag filed Critical Syngenta Crop Protection Ag
Publication of WO2023094303A1 publication Critical patent/WO2023094303A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00—Fungicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28—Cinnolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Definitions

  • the present invention relates to heterobiaryl amide derivatives, e.g., as active ingredients, which have microbiocidal activity, in particular, fungicidal activity.
  • the invention also relates to agrochemical compositions which comprise at least one of the heterobiaryl amide derivatives, to processes of preparation of these compounds and to uses of the heterobiaryl amide derivatives or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi.
  • WO 2020/109391 discloses the use of pyridazine (thio)amide derivatives for controlling phytopathogenic microorganisms.
  • WO 2021/233861 discloses the use of azabicyclic(thio)amides derivatives as fungicidal compounds.
  • WO 2021/249995 discloses the use of azabicyclyl-oxadiazole derivatives as fungicidal compounds.
  • R 1 is phenyl substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, Ci-Cs-alkylsulfanyl, Ci-Cs-alkylsulfinyl, C1-C3- alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
  • R 1 is phenyl optionally substituted by 1 , 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, /so-propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or
  • R 1 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, Ci-C2-haloalkyl, C1- C4-alkoxy, Ci-C3-alkylsulfanyl, Ci-C3-alkylsulfinyl, Ci-C3-alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
  • R 1 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is optionally substituted by 1 or 2 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, iso- propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy;
  • R 2 and R 3 are each independently selected from hydrogen, and Ci-C4-alkyl; or
  • R 2 and R 3 together with the carbon atom to which they are attached, form a Cs-Ce-cycloalkyl group
  • R 4 and R 5 are each independently selected from hydrogen, halogen, cyano, hydroxy, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, and Ci-C4-haloalkoxy; or
  • R 4 and R 5 together with the carbon atom to which they are attached, form an oxo or a C3-C6- cycloalkyl group;
  • R 6 is phenyl substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, Ci-Cs-alkylsulfanyl, Ci-C3-alkylsulfinyl, C1-C3- alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
  • R 6 is phenyl optionally substituted by 1 , 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, /so-propyloxy, te/Y-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or
  • R 6 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is substituted by a single substituent selected from hydrogen, hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, C1-C2- haloalkyl, Ci-C4-alkoxy, Ci-C3-alkylsulfanyl, Ci-C3-alkylsulfinyl, Ci-C3-alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
  • R 6 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is optionally substituted by 1 , 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, /so-propyloxy, te/Y-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy;
  • Y 1 , Y 2 , Y 3 , and Y 4 are each independently selected from N and CR 7 , with the proviso that at least two of Y 1 , Y 2 , Y 3 , and Y 4 are selected from N and CH;
  • R 7 is independently selected from hydrogen, halogen, cyano, hydroxy, mercapto, Ci-Cs-alkyl, C1- Cs-alkoxy, Ci-Cs-haloalkyl, Ci-Cs-haloalkoxy, Ci-Cs-alkylsulfonyl, C2-C3-alkynyl, and C3-C4-cycloalkyl;
  • Z 1 is N or CR 8 , wherein R 8 is selected from hydrogen, halogen, cyano, hydroxy, Ci-Cs-alkyl, C1- Cs-alkoxy, Ci-Cs-haloalkyl, Ci-Cs-haloalkoxy, Ci-Cs-alkylsulfonyl, C2-C3-alkenyl, C2-C3-alkynyl, and C3- C4-cycloalkyl; or an agrochemically acceptable salt, stereoisomer, enantiomer, and N-oxide of the compound of formula (I).
  • an agrochemical composition comprising a fungicidally effective amount of a compound of Formula (I).
  • Such an agricultural composition may further comprise at least one additional active ingredient and/or an agrochemically- acceptable diluent or carrier.
  • a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms wherein a fungicidally effective amount of a compound of Formula (I), or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
  • a compound of Formula (I) as a fungicide.
  • the use may exclude methods for the treatment of the human or animal body by surgery or therapy.
  • hydroxyl or “hydroxy” means an -OH group.
  • mercapto means an -SH group.
  • cyano means a -CN group.
  • amino means an -NH2 group.
  • nitro means an -NO2 group.
  • halogen refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine.
  • Ci-4alkyl refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to four carbon atoms, and which is attached to the rest of the molecule by a single bond. Ci-salkyl should be construed accordingly. Examples of Ci-4alkyl include, but are not limited to, methyl, ethyl, /so-propyl.
  • C2-3alkenyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond that may be of either the (E) or (Z) configuration, having two or three carbon atoms, which is attached to the rest of the molecule by a single bond.
  • Examples of Cs salkenyl include, but are not limited to, vinyl (ethenyl), prop-1 -enyl and allyl (prop-2-enyl).
  • Cs-shaloalkenyl refers to a Cs salkenyl group as defined above substituted by one or more of the same or different halogen atoms.
  • C2-3alkynyl refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two or three carbon atoms, and which is attached to the rest of the molecule by a single bond.
  • Examples of C2-3alkynyl include, but are not limited to, ethynyl, prop-1-ynyl and propargyl (prop-2-ynyl).
  • Ci-3alkoxy refers to a radical of the formula R a O- where R a is a Cisalkyl radical as generally defined above.
  • Examples of Ci-salkoxy include, but are not limited to, methoxy, ethoxy and /so-propoxy.
  • Ci-4haloalkyl refers to a Ci ⁇ alkyl radical as generally defined above substituted by one or more of the same or different halogen atoms.
  • Ci-4haloalkyl include, but are not limited to fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl and 2,2,2-trifluoroethyl.
  • C1-3fluoroalkyl refers to a C1-3alkyl radical as generally defined above substituted by one or more fluorine atoms. Examples of C1-3fluoroalkyl include, but are not limited to difluoromethyl and trifluoromethyl.
  • C1-3fluoroalkoxy refers to a C1-3alkoxy radical as generally defined above substituted by one or more fluorine atoms. Examples of C1-3fluoroalkoxy include, but are not limited to trifluoromethoxy.
  • C3-4cycloalkyl refers to a stable, monocyclic ring radical which is saturated and contains 3 or 4 carbon atoms.
  • C1-3alkylsulfanyl refers to a radical of the formula -SRa wherein Ra is a C1-3alkyl radical as generally defined above.
  • C1-3alkylsulfonyl refers to a radical of the formula -S(O)2Ra wherein Ra is a C1-3alkyl radical as generally defined above.
  • heteroaryl refers to a 5- or 6-membered aromatic monocyclic ring having 1, 2 or 3 heteroatoms independently selected from N, O and S. Examples are heteroaryls J-1 to J-31 shown in Table J below. Table J: Heteroaryl J-1 to J-31:
  • a group optionally substituted by 1 , 2 or 3 substituents means that the group may be unsusbstituted, or that one, two or three hydrogen atoms of the group are replaced with a susbstituent.
  • the expression “1 , 2 or 3 substituents each independently selected from” or “1 , 2 or 3 heteroatoms each independently selected from” means that the substituents or heteroatoms, as the case may be, may be all the same, all different from each other, or, when 3 substituents or heteroatoms are considered, that two of them are the same and the third is different from the former two.
  • the heteroatoms may be all the same, for example only nitrogen atoms, or different, for instance one or two nitrogen atoms and one oxgen atom, or one or two nitrogen atom and one sulfur atom. Examples of heteroaryl rings are shown in Table J above, with heteroaryls J-1 to J-31 .
  • asymmetric carbon atoms in a compound of Formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also, atropisomers may occur as a result of restricted rotation about a single bond.
  • Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of Formula (I).
  • Formula (I) is intended to include all possible tautomers (including lactam-lactim tautomerism and ketoenol tautomerism) where present. The present invention includes all possible tautomeric forms for a compound of Formula (I).
  • the compounds of Formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form.
  • N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
  • Y 1 , Y 2 , Y 3 , and Y 4 are each independently selected from N and CR 7 , with the proviso that at least two of Y 1 , Y 2 , Y 3 , and Y 4 are selected from N and CH; and Z 1 is N; or
  • Y 1 , Y 2 , Y 3 , and Y 4 are each independently selected from N and CR 7 , with the proviso that at least two of Y 1 , Y 2 , Y 3 , and Y 4 are selected from N and CH; and Z 1 is CR 8 ; or
  • Y 1 , Y 2 , Y 3 , and Y 4 are each independently selected from N and CR 7 , with the proviso that at least two of Y 1 , Y 2 , Y 3 , and Y 4 are selected from N and CH; and Z 1 is CH; or D. one of Y 1 , Y 2 , Y 3 , and Y 4 is N, another one of Y 1 , Y 2 , Y 3 , and Y 4 is CH; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is N; or E.
  • two of Y 1 , Y 2 , Y 3 , and Y 4 are N; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is N; or F.
  • two of Y 1 , Y 2 , Y 3 , and Y 4 are CH; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is N; or G.
  • one of Y 1 , Y 2 , Y 3 , and Y 4 is N; another one of Y 1 , Y 2 , Y 3 , and Y 4 is CH; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is CR 8 ; or H.
  • two of Y 1 , Y 2 , Y 3 , and Y 4 are N; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is CR 8 ; or I.
  • Y 1 , Y 2 , Y 3 , and Y 4 are CH; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is CR 8 ; or J. one of Y 1 , Y 2 , Y 3 , and Y 4 is N; another one of Y 1 , Y 2 , Y 3 , and Y 4 is CH; the other two of Y 1 , Y 2 , Y 3 , and Y 4 are CR 7 ; and Z 1 is CH; or K.
  • R 7 is selected from: A.
  • R 8 is selected from: A.
  • the heterobiaryl moiety formed with Y 1 , Y 2 , Y 3 , Y 4 , Z 1 is selected from the groups (Ia) to (Iv) shown in Table L, where R 7 has the same meaning as given above for compounds of the formula (I), m equals 0 or 1, and where the staggered lines represent the points of attachment of the heterobiaryl moiety to the remainder of the compound of formula (I): Table L: Heterobiaryl (Ia) to (Iv) As shown in Table L, in preferred embodiments of compounds of formula (I), Z 1 is CH (i.e.
  • Y 1 , Y 2 , Y 3 , and Y 4 are N, and the others are CH
  • R 7 is selected from: A. hydrogen, halogen, methyl, trifluoromethyl, methoxy, methylsulfonyl, difluoromethoxy, ethynyl, and cyclopropyl; or B.
  • the heterobiaryl moiety formed with Y 1 , Y 2 , Y 3 , Y 4 , Z 1 is selected from the groups (Ia), (Ib), (Ic), (Id), (Ie), (Ig), (Ih) and (Ii), and m equals 0: Most preferably, the heterobiaryl moiety formed with Y 1 , Y 2 , Y 3 , Y 4 , Z 1 is group (Ia), i.e.
  • R 1 is selected from: A. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2- haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3-alkylsulfonyl, C1-C2- haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C
  • phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, chloro, fluoro, bromo, mercapto, amino, cyano, methyl, ethyl, vinyl, allyl, 2,2-difluorovinyl, ethynyl, prop-1-ynyl, propargyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or C.
  • phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C2-alkyl, C1-C2- fluoroalkyl, C1-C2-alkoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, prop-1-ynyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or D.
  • phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, chloro, fluoro, amino, cyano, methyl, ethyl, vinyl, prop-1-ynyl, propargyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or E.
  • phenyl, pyridyl, pyrimidinyl or thienyl wherein the phenyl, pyridyl, pyrimidinyl or thienyl is optionally substituted by 1 or 2 substituents each independently selected from hydroxyl, chloro, fluoro, amino, cyano, methyl, trifluoromethyl, methoxy, ethoxy, methylsulfanyl, methylsulfinyl, methylsulfonyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or F.
  • phenyl, pyridyl, pyrimidinyl or thienyl wherein the phenyl, pyridyl, pyrimidinyl or thienyl is substituted by a single substituent selected from hydroxyl, chloro, fluoro, amino, cyano, methyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or G.
  • phenyl, pyridyl, pyrimidinyl or thienyl wherein the phenyl, pyridyl, pyrimidinyl or thienyl is optionally substituted by 1 or 2 substituents each independently selected from methyl, chloro, fluoro, trifluoromethyl, methylsulfonyl, vinyl, ethynyl, propargyl, cyclopropyl, and cyclopropyloxy; or H.
  • phenyl, pyridyl, pyrimidinyl or thienyl wherein the phenyl, pyridyl, pyrimidinyl or thienyl is substituted by a single substituent selected from methyl, chloro, fluoro, trifluoromethyl, methoxy, methylsulfonyl, ethynyl, prop-1-ynyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or I.
  • phenyl 3-methylphenyl, 3-chlorophenyl, 3-cyclopropylphenyl, 3-ethynylphenyl, 3- trifluoromethylphenyl, 3-cyclopropyl-2-fluorophenyl, and 3-pyridyl optionally substituted by methyl, chloro, fluoro, cyano, trifluoromethyl, methylsulfonyl, ethynyl, cyclopropyl, or cyclopropyloxo; or J.
  • R 2 and R 3 are as follows: A.
  • R 2 and R 3 are each independently selected from hydrogen and C1-C3-alkyl; or B. R 2 is C1-C3-alkyl, and R 3 is hydrogen or C1-C3-alkyl different from R 2 ; or C. R 2 and R 3 are each independently selected from hydrogen, methyl, ethyl, propyl, and methylethyl; or D. R 2 is methyl, ethyl, propyl, and methylethyl, and R 3 is hydrogen; or E. R 2 is methyl or ethyl, and R 3 is hydrogen; or F. R 2 is methyl, and R 3 is hydrogen; or G. R 2 and R 3 are each independently selected from hydrogen and methyl; or H. hydrogen.
  • R 2 and R 3 are hydrogen.
  • R 4 and R 5 are as follows: A. R 4 and R 5 are each independently selected from hydrogen, halogen, C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, and C1-C3-haloalkoxy; or R 4 and R 5 together with the carbon atom to which they are attached, form an oxo, cyclopropyl, or cyclobutyl group; or B.
  • R 4 and R 5 are each independently selected from hydrogen, fluoro, chloro, bromo, methyl, ethyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, difluoromethoxy; or R 4 and R 5 together with the carbon atom to which they are attached, form a cyclopropyl group; or C.
  • R 4 and R 5 are each independently selected from hydrogen, fluoro, chloro, methyl, ethyl, and methoxy; or R 4 and R 5 together with the carbon atom to which they are attached, form an oxo or a cyclopropyl group; or D.
  • R 4 and R 5 are each independently selected from hydrogen, fluoro, and methyl; or R 4 and R 5 together with the carbon atom to which they are attached, form a cyclopropyl group; or E. R 4 and R 5 are each independently selected from hydrogen and fluoro; or R 4 and R 5 together with the carbon atom to which they are attached, form a cyclopropyl group; or F. R 4 and R 5 are each independently selected from hydrogen and fluoro; or G. R 4 and R 5 are differently selected from hydrogen and fluoro.
  • R 6 is selected from: A.
  • phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2- haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3-alkylsulfonyl, C1-C2- haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, and C3-C6- cycloalkyloxy; or B.
  • phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, chloro, fluoro, bromo, mercapto, amino, cyano, methyl, ethyl, vinyl, allyl, 2,2-difluorovinyl, ethynyl, prop-1-ynyl, propargyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or C.
  • phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, chloro, fluoro, bromo, cyano, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, prop-1-ynyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or D.
  • phenyl, 2-pyridyl, 3-pyridyl and 4-pyridyl wherein the phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl is optionally substituted by one or two substituents each independently selected from chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, methoxy, methylsulfonyl, difluoromethoxy, vinyl, allyl, and ethynyl; or E.
  • phenyl 4-tolyl, 2,4-dichlorophenyl, 2-pyridyl, 2,4-difluorophenyl, 4-pyridyl, 2,4-dibromophenyl, 5- bromo-2-pyridyl, 2,4-dimethylphenyl, 3,5-dichloro-2-pyridyl, 2-chloro-4-fluorophenyl, 3-chloro-2- pyridyl, 2-chloro-4-bromophenyl, 3-chloro-5-methyl-2-pyridyl, 2-chloro-4-methylphenyl, 6-chloro-3- pyridyl, 2-chlorophenyl, and 4,6-dichloro-3-pyridyl.
  • the compound according to Formula (I) is compound 1.1 listed in Table T1 (below).
  • the compounds of the present invention may be enantiomers of the compound of Formula (I) as represented by Formula (I-1) or Formula (I-2) or Formula (I-3) or Formula (I-4), wherein R 2 and R 3 are different substituents and/or wherein R 4 and R 5 are different substituents.
  • the compounds of formula (I) are can be obtained by an amide-coupling transformation with compounds of formula (II), wherein X 1 is OH and amine compounds of formula (III) by activating the carboxylic acid function of the compounds of formula (II), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as an acyl chloride group for example by using (COCl)2 or SOCl2, prior to treatment with the compounds of formula (III), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane, tetrahydrofuran, 2-methyl-tetrahydrofuran, EtOAc and the like), preferably at temperatures between 25°C and 60°C, and optionally in the presence of a base such as triethylamine, N,N- diisopropylethylamine or dimethylaminopyridine.
  • a suitable solvent
  • such amide couplings can be achieved using compounds of formula (II), wherein X 1 is OH, with amines of formula (III), using a suitable activating agent such as 1-propanephosphonic acid cyclic anhydride (T3P) in suitable solvent (e.g., acetonitrile), optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine).
  • T3P 1-propanephosphonic acid cyclic anhydride
  • suitable solvent e.g., acetonitrile
  • a base e.g., triethylamine or N,N-diisopropylethylamine
  • compounds of formula (I) can be obtained by an amide-coupling transformation with compounds of formula (II), wherein X 1 is C1-C4alkoxy, and amine compounds of formula (III) in the presence of a suitable lewis acid, such as methylaluminium dichloride, trimethylaluminium, or DABAL- Me3 (an adduct of trimethylaluminum and DABCO®) in the presence of compounds of formula (III) in a suitable solvent such as toluene and at temperatures between 20°C and 90°C.
  • a suitable lewis acid such as methylaluminium dichloride, trimethylaluminium, or DABAL- Me3 (an adduct of trimethylaluminum and DABCO®
  • a metal catalyst complex e.g. Cu or Pd.
  • a suitable solvent e.g. N-methylpyrrolidone, dimethylacetamide, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran, sulfolane, dimethylsulfoxide
  • a metal catalyst complex e.g. Cu or Pd
  • a base e.g., NaOH, LiOH
  • suitable solvent mixture e.g., tetrahydrofuran/water
  • a metal source e.g. Cu(OAc)2
  • an oxidant such as O2 or a suitable palladium pre-catalyst, such as RockPhos Pd G3
  • a base e.g. K3PO4
  • suitable solvent e.g. dimethyl ether or toluene
  • a metal source e.g. Cu(OAc)2
  • an oxidant such as O2 or a suitable palladium pre-catalyst, such as RockPhos Pd G3
  • a base e.g. K3PO4
  • a suitable solvent e.g.toluene
  • the compounds of Formula (I) of the present invention have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
  • the compounds of Formula (I) can be used in the agricultural sector and related fields of use, e.g., as active ingredients for controlling plant pests or on non-living materials for the control of spoilage microorganisms or organisms potentially harmful to man.
  • the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and can be used for protecting numerous cultivated plants.
  • the compounds of Formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later, e.g., from phytopathogenic microorganisms.
  • the present invention further relates to a method for controlling or preventing infestation of plants or plant propagation material and/or harvested food crops susceptible to microbial attack by treating plants or plant propagation material and/or harvested food crops wherein an effective amount a compound of Formula (I) is applied to the plants, to parts thereof or the locus thereof.
  • fungicide as used herein means a compound that controls, modifies, or prevents the growth of fungi.
  • fungicidally effective amount where used means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all dev/ation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.
  • compositions of Formula (I) can be used as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings, for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil.
  • the propagation material can be treated with a composition comprising a compound of Formula (I) before planting: seed, for example, can be dressed before being sown.
  • the active compounds of Formula (I) can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation.
  • the composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing.
  • the invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
  • the compounds of Formula (I) can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management.
  • the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
  • the compounds of Formula (I) are for example, effective against fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses.
  • These fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses are for example:
  • Absidia corymbifera Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. comprising B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C.
  • Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp.
  • P. infestans Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P.
  • the compounds of Formula (I) may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.
  • target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St.
  • perennial and annual crops such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries
  • cereals for example barley, maize (corn), millet, oats
  • Augustine grass and Zoysia grass herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
  • herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme
  • legumes for example beans, lentils, peas and soya beans
  • useful plants is to be understood as also including useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol- pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering.
  • herbicides like bromoxynil or classes of herbicides
  • EPSPS (5-enol- pyrovyl-shikimate-3-phosphate-synthase) inhibitors
  • GS glutamine synthetase
  • PPO protoporphyrinogen-oxidase
  • imazamox by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola).
  • crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.
  • useful plants is to be understood as also including useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • YieldGard® (maize variety that expresses a CrylA(b) toxin); YieldGard Rootworm® (maize variety that expresses a CrylllB(bl) toxin); YieldGard Plus® (maize variety that expresses a CrylA(b) and a CrylllB(bl) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CrylF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylA(c) toxin); Bollgard I® (cotton variety that expresses a CrylA(c) toxin); Bollgard II® (cotton variety that expresse
  • crops is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
  • Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as 8-endotoxins, e.g. CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp.
  • insecticidal proteins from Bacillus cereus or Bacillus popilliae such as 8-endotoxins, e.g. CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins
  • Xenorhabdus spp. such as Photorhabdus luminescens, Xenorhabdus nematophilus
  • toxins produced by animals such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins
  • toxins produced by fungi such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins
  • agglutinins proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors
  • steroid metabolism enzymes such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecd
  • 8-endotoxins for example CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins.
  • Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701).
  • Truncated toxins for example a truncated CrylAb, are known.
  • modified toxins one or more amino acids of the naturally occurring toxin are replaced.
  • amino acid replacements preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
  • Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO93/07278, WO95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
  • Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.
  • the toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects.
  • insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).
  • Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available.
  • YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylAc toxin); Bollgard I® (cotton variety that expresses a CrylAc toxin); Bollgard II® (cotton variety that expresses a CrylAc and a Cry2Ab toxin
  • transgenic crops are:
  • MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
  • MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
  • NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810.
  • NK603 x MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1 Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
  • locus means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.
  • plants refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.
  • plant propagation material is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes.
  • vegetative material such as cuttings or tubers, for example potatoes.
  • seeds in the strict sense
  • roots in the strict sense
  • fruits in the tubers
  • bulbs rhizomes
  • parts of plants there can be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants.
  • Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil may also be mentioned. These young plants can be protected before transplantation by a total or partial treatment by immersion.
  • plant propagation material is understood to denote seeds.
  • the compounds of Formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently Formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
  • Suitable carriers and adjuvants can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers.
  • Such carriers are for example described in WO 97/33890.
  • Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers.
  • the particles contain the active ingredient retained in a solid matrix.
  • Typical solid matrices include fuller’s earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.
  • Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
  • Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required.
  • Typical carriers for granular Formulations include sand, fuller’s earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound.
  • Granular formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils
  • Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
  • Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates.
  • Encapsulated droplets are typically 1 to 50 microns in diameter.
  • the enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound.
  • Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores.
  • Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring.
  • Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.
  • compositions for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents.
  • Pressurised sprayers wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.
  • Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.
  • Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1 ,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl formamide, dimethyl sulfoxide, 1 ,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol
  • Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller’s earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.
  • a broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application.
  • These agents when used, normally comprise from 0.1 % to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes.
  • Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub.
  • alcohol-alkylene oxide addition products such as tridecyl alcohol-C.sub. 16 ethoxylate
  • soaps such as sodium stearate
  • alkylnaphthalenesulfonate salts such as sodium dibutylnaphthalenesulfonate
  • dialkyl esters of sulfosuccinate salts such as sodium di(2-ethylhexyl) sulfosuccinate
  • sorbitol esters such as sorbitol oleate
  • quaternary amines such as lauryl trimethylammonium chloride
  • polyethylene glycol esters of fatty acids such as polyethylene glycol stearate
  • salts of mono and dialkyl phosphate esters such as mono and dialkyl phosphate esters.
  • adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti-foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.
  • biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.
  • Pesticidal agents are referred to herein using their common name are known, for example, from “The Pesticide Manual”, 15th Ed., British Crop Protection Council 2009.
  • compositions of the invention may also be applied with one or more systemically acquired resistance inducers (“SAR” inducer).
  • SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.
  • the compounds of Formula (I) are normally used in the form of agrochemical compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds.
  • further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non- selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
  • the compounds of Formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of Formula (I) or of at least one preferred individual compound as defined herein, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
  • the invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound Formula (I) an agriculturally acceptable carrier and optionally an adjuvant.
  • An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use.
  • Agricultural carriers are well known in the art.
  • said composition may comprise at least one or more pesticidally-active compounds, for example an additional fungicidal active ingredient in addition to the compound of Formula (I).
  • the compound of Formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate.
  • An additional active ingredient may, in some cases, result in unexpected synergistic activities.
  • Suitable additional active ingredients include the following: acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fung
  • suitable additional active ingredients also include a compound selected from the group of substances consisting of petroleum oils, 1 ,1-bis(4-chlorophenyl)-2-ethoxyethanol, 2,4- dichlorophenyl benzenesulfonate, 2-fluoro-N-methyl-N-1 -naphthylacetamide, 4-chlorophenyl phenyl sulfone, acetoprole, aldoxycarb, amidithion, amidothioate, amiton, amiton hydrogen oxalate, amitraz, aramite, arsenous oxide, azobenzene, azothoate, benomyl, benoxafos, benzyl benzoate, bixafen, brofenvalerate, bromocyclen, bromophos, bromopropylate, buprofezin, butocarboxim, butoxycarboxim, butylpyridaben, calcium polysulf
  • lecontei NPV, Orius spp. Paecilomyces fumosoroseus, Phytoseiulus persimilis, Steinernema bibionis, Steinernema carpocapsae, Steinernema feltiae, Steinernema glaseri, Steinernema riobrave, Steinernema riobravis, Steinernema scapterisci, Steinernema spp., Trichogramma spp., Typhlodromus occidentalis, Verticillium lecanii, apholate, bisazir, busulfan, dimatif, hemel, hempa, metepa, methiotepa, methyl apholate, morzid, penfluron, tepa, thiohempa, thiotepa, tretamine, uredepa, (E)-dec-5-en-1-yl acetate
  • TX means one compound selected from the group consisting of the compounds as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below): a compound selected from the group of substances consisting of petroleum oils + TX, 1 , 1 -bis(4- chlorophenyl)-2-ethoxyethanol + TX, 2,4-dichlorophenyl benzenesulfonate + TX, 2-fluoro-N-methyl-N- 1 -naphthylacetamide + TX, 4-chlorophenyl phenyl sulfone + TX, acetoprole + TX, aldoxycarb + TX, amidithion + TX, amidothioate + TX, amiton + TX, amiton hydrogen oxa
  • TX Paecilomyces fumosoroseus + TX, Phytoseiulus persimilis + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp. + TX, Trichogramma spp.
  • the compounds in this paragraph may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3- pyridyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol + TX (this compound may be prepared from the methods described in WO 2017/029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1 ,2,4-triazol-1- yl)propan-2-ol + TX (this compound may be prepared from the methods described in WO 2017/029179); 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + TX (this compound may be prepared from the methods described in
  • the active ingredient mixture of the compounds of formula (I) selected from one compound as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below) is preferably in a mixing ratio of from 100:1 to 1 :6000, especially from 50:1 to 1 :50, more especially in a ratio of from 20:1 to 1 :20, even more especially from 10:1 to 1 :10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5:1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or
  • the mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
  • the mixtures comprising a compound as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below), and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days.
  • the order of applying a compound as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below) and the active ingredient(s) as described above, is not essential for working the present invention.
  • the compounds of the invention may also be used in combination with anthelmintic agents.
  • Such anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP- 444964 and EP-594291 .
  • Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO- 9522552.
  • Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.
  • the compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE-19520936.
  • the compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/1 1945, WO 93/19053, WO 93/25543, EP 0 626 375, EP 0 382 173, WO 94/19334, EP 0 382 173, and EP 0 503 538.
  • the compounds of the invention may be used in combination with other ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
  • ectoparasiticides for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
  • the compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein.
  • Organophosphates acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, me
  • Carbamates alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801 , isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
  • Pyrethroids acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E)-(1 R)-cis-2,2-dimethyl- 3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta-cyfluthrin, cyfluthrin, a- cypermethrin, beta-cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvaler
  • Arthropod growth regulators a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.
  • antiparasitics acequinocyl, amitraz, AKD-1022, ANS-118, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydr
  • Biological agents Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.
  • Bactericides chlortetracycline, oxytetracycline, streptomycin.
  • compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
  • auxiliaries such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides
  • compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries).
  • Another aspect of the invention is related to the use of a compound of Formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, or of a fungicidal or insecticidal mixture comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
  • a further aspect of the invention is related to a method of controlling or preventing an infestation of plants, e.g., useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of Formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
  • useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms
  • a compound of Formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts
  • Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
  • a preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of Formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application.
  • the frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect.
  • the compounds of Formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid Formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
  • the compounds of Formula (I) may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
  • a formulation e.g. a composition containing the compound of Formula (I), and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of Formula (I), may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • extenders for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i./ha, most preferably from 20g to 600g a.i./ha.
  • convenient dosages are from 10mg to 1g of active substance per kg of seeds.
  • a composition comprising a compound of Formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.
  • compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EG), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK
  • compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects).
  • appropriate formulation inerts diiluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects.
  • conventional slow release formulations may be employed where long lasting efficacy is intended.
  • Particularly Formulations to be applied in spraying forms such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g.
  • a seed dressing formulation is applied in a manner known per se to the seeds employing the combination ofthe invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • suitable seed dressing formulation form e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds.
  • seed dressing formulations are known in the art.
  • Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules.
  • the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of Formula (I) optionally together with other active agents, particularly microbiocides or conservatives or the like.
  • Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent.
  • Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations.
  • Table G This table discloses 100 substituent definitions (G) of compounds of the formula (I), according to the invention, wherein G (comprising -N(H)-, R 2 , R 3 , R 4 , R 5 and R 6 ) according to compounds of Formula (I) of the invention is and wherein the G substituents are as defined below in Table G:
  • Tables A1 show specific compounds of formula (IA) wherein G substituents are as defined above in Table G.
  • Q corresponds to R 1 in formula (I).
  • Table A1 This table provides 100 compounds A1-1 to A1-100 of formula (IA) wherein Q is 3-methyl- phenyl, and G is as defined above in Table G.
  • compound A1-52 has the following structure:
  • Table A2 This table provides 100 compounds A2-1 to A2-100 of formula (IA) wherein Q is 3-phenyl and G is as defined above in Table G.
  • Table A3 This table provides 100 compounds A3-1 to A3-100 of formula (IA) wherein Q is 3- chlorophenyl and G is as defined above in Table g.
  • Table A4 This table provides 100 compounds A4-1 to A4-100 of formula (IA) wherein Q is 3- cyclopropylphenyl and G is as defined above in Table G.
  • Table A5 This table provides 100 compounds A5-1 to A5-100 of formula (IA) wherein Q is 3- ethynylphenyl and G is as defined above in Table g.
  • Table A6 This table provides 100 compounds A6-1 to A6-100 of formula (IA) wherein Q is 3- trifluoromethylphenyl and G is as defined above in Table G.
  • Table A7 This table provides 100 compounds A7-1 to A7-100 of formula (IA) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
  • Table A8 This table provides 100 compounds A8-1 to A8-100 of formula (IA) wherein Q is 3-pyridyl and G is as defined above in Table G.
  • Table A9 This table provides 100 compounds A9-1 to A9-100 of formula (IA) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
  • Table A10 This table provides 100 compounds A10-1 to A10-100 of formula (IA) wherein Q is 5-fluoro-
  • Table A11 This table provides 100 compounds A11 -1 to A11 -100 of formula (IA) wherein Q is 5-methyl- 3-pyridyl and G is as defined above in Table G.
  • Table A12 This table provides 100 compounds A12-1 to A12-100 of formula (IA) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G.
  • Tables B1 to B12 show specific compounds of formula (IB) whose G substituents are as defined above in Table G.
  • Q corresponds to R 1 in formula (I).
  • Table B1 This table provides 100 compounds B1-1 to B1-100 of formula (IB) wherein Q is phenyl and
  • compound B1-90 has the following structure:
  • Table B2 This table provides 100 compounds B2-1 to B2-100 of formula (IB) wherein Q is 3- methylphenyl and G is as defined above in Table G.
  • Table B3 This table provides 100 compounds B3-1 to B3-100 of formula (IB) wherein Q is 3- chlorophenyl and G is as defined above in Table G.
  • Table B4 This table provides 100 compounds B4-1 to B4-100 of formula (IB) wherein Q is 3- cyclopropyl-phenyl and G is as defined above in Table G.
  • Table B5 This table provides 100 compounds B5-1 to B5-100 of formula (IB) wherein Q is 3- ethynylphenyl and G is as defined above in Table G.
  • Table B6 This table provides 100 compounds B6-1 to B6-100 of formula (IB) wherein Q is 3- trifluoromethylphenyl and G is as defined above in Table G.
  • Table B7 This table provides 100 compounds B7-1 to B7-100 of formula (IB) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
  • Table B8 This table provides 100 compounds B8-1 to B8-100 of formula (IB) wherein Q is 3-pyridyl and G is as defined above in Table G.
  • Table B9 This table provides 100 compounds B9-1 to B9-100 of formula (IB) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
  • Table B10 This table provides 100 compounds B10-1 to B10-100 of formula (IB) wherein Q is 5-fluoro- 3-pyridyl and G is as defined above in Table G.
  • Table B11 This table provides 100 compounds B11 -1 to B11 -100 of formula (IB) wherein Q is 5-methyl-
  • Table B12 This table provides 100 compounds B12-1 to B12-100 of formula (IB) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G.
  • Tables C1 to C12 show specific compounds of formula (IC) whose G substituents are as defined above in Table G.
  • Q corresponds to R 1 in formula (I).
  • Table C1 This table provides 100 compounds C1-1 to C1-100 of formula (IC) wherein Q is 3- trifluoromethyl-phenyl and G is as defined above in Table G.
  • compound C1-67 has the following structure: Compound C1-67 Table C2: This table provides 100 compounds C2-1 to C2-100 of formula (IC) wherein Q is 3-phenyl and G is as defined above in Table G.
  • Table C3 This table provides 100 compounds C3-1 to C3-100 of formula (IC) wherein Q is 3- methylphenyl and G is as defined above in Table G.
  • Table C4 This table provides 100 compounds C4-1 to C4-100 of formula (IC) wherein Q is 3- chlorophenyl and G is as defined above in Table G.
  • Table C5 This table provides 100 compounds C5-1 to C5-100 of formula (IC) wherein Q is 3- cyclopropylphenyl and G is as defined above in Table G.
  • Table C6 This table provides 100 compounds C6-1 to C6-100 of formula (IC) wherein Q is 3- ethynylphenyl and G is as defined above in Table G.
  • Table C7 This table provides 100 compounds C7-1 to C7-100 of formula (IC) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
  • Table C8 This table provides 100 compounds C8-1 to C8-100 of formula (IC) wherein Q is 3-pyridyl and G is as defined above in Table G.
  • Table C9 This table provides 100 compounds C9-1 to C9-100 of formula (IC) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
  • Table C10 This table provides 100 compounds C10-1 to C10-100 of formula (IC) wherein Q is 5-fluoro- 3-pyridyl and G is as defined above in Table G.
  • Table C11 This table provides 100 compounds C11-1 to C11-100 of formula (IC) wherein Q is 5-methyl- 3-pyridyl and G is as defined above in Table G.
  • Table C12 This table provides 100 compounds C12-1 to C12-100 of formula (IC) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G.
  • Tables D1 to D12 show specific compounds or formula (ID) whose G substituents are as defined above in Table G.
  • Q corresponds to R 1 in formula (I).
  • Table D1 This table provides 100 compounds D1-1 to D1-100 of formula (ID) wherein Q is 3-ethynyl- phenyl and G is as defined above in Table G.
  • compound D1-73 has the following structure:
  • Table D2 This table provides 100 compounds D2-1 to D2-100 of formula (ID) wherein Q is 3-phenyl and G is as defined above in Table G.
  • Table D3 This table provides 100 compounds D3-1 to D3-100 of formula (ID) wherein Q is 3- methylphenyl and G is as defined above in Table G.
  • Table D4 This table provides 100 compounds D4-1 to D4-100 of formula (ID) wherein Q is 3- chlorophenyl and G is as defined above in Table G.
  • Table D5 This table provides 100 compounds D5-1 to D5-100 of formula (ID) wherein Q is 3- cyclopropylphenyl and G is as defined above in Table G.
  • Table D6 This table provides 100 compounds D6-1 to D6-100 of formula (ID) wherein Q is 3- trifluoromethylphenyl and G is as defined above in Table G.
  • Table D7 This table provides 100 compounds D7-1 to D7-100 of formula (ID) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
  • Table D8 This table provides 100 compounds D8-1 to D8-100 of formula (ID) wherein Q is 3-pyridyl and G is as defined above in Table G.
  • Table D9 This table provides 100 compounds D9-1 to D9-100 of formula (ID) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
  • Table D10 This table provides 100 compounds D10-1 to E10-100 of formula (ID) wherein Q is 5-fluoro- 3-pyridyl and G is as defined above in Table G.
  • Table D11 This table provides 100 compounds D11-1 to D11-100 of formula (ID) wherein Q is 5-methyl- 3-pyridyl and G is as defined above in Table G.
  • Table D12 This table provides 100 compounds D12-1 to D12-100 of formula (ID) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G.
  • the compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1 .5 ppm, 0.8 ppm or 0.2 ppm.
  • Compounds of Formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico-chemical properties, or increased biodegradability).
  • Solvent A Water with 0.1 % formic acid : Acetonitrile : : 95 : 5 v/v
  • Solvent B Acetonitrile with 0.1 % formic acid
  • enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, eg, by using chiral starting materials.
  • Wettable powders a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 % sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate 6 % 10 % phenol polyethylene glycol ether 2 % (7-8 mol of ethylene oxide) highly dispersed silicic acid 5 % 10 % 10 %
  • the active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
  • Powders for dry seed treatment a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 %
  • Talcum 20 % The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
  • Emulsifiable concentrate active ingredient [compound of formula (I)] 10 % octylphenol polyethylene glycol ether 3 %
  • Emulsions of any required dilution which can be used in plant protection, can be obtained from this concentrate by dilution with water.
  • Active ingredient [compound of formula (I)] 5 % 6 % 4 %
  • Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
  • Active ingredient [compound of formula (I)] 15 % sodium lignosulfonate 2 % Carboxymethylcellulose 1 %
  • the active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water.
  • the mixture is extruded and then dried in a stream of air.
  • Active ingredient 8 % polyethylene glycol (mol. wt. 200) 3 %
  • the finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
  • Suspension concentrate active ingredient [compound of formula (I)] 40 % propylene glycol 10 % nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 %
  • Carboxymethylcellulose 1 % silicone oil (in the form of a 75 % emulsion in water) 1 %
  • the finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • Flowable concentrate for seed treatment active ingredient [compound of formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 %
  • Silicone oil (in the form of a 75 % emulsion in water) 0.2 %
  • the finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water.
  • living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
  • the obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent.
  • the capsule suspension formulation contains 28% of the active ingredients.
  • the medium capsule diameter is 8-15 microns.
  • the resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
  • LC/MS Liquid Chromatography Mass Spectrometry (description of the apparatus and the methods used for LC/MS analysis are given above)
  • Step B Preparation of methyl 3-(3-cyclopropylphenoxy)quinoline-4-carboxylate
  • Lithium hydroxide hydrate (0.060 g, 1.4 mmol) was added and the resulting mixture was stirred for 2 days at RT. The solvent was evaporated in vacuo and the residue was taken up in water and ethyl acetate. The aqueous layer was extracted with ethyl acetate and the organic layer obtained discarded. Then, 2M HCl was added to the aqueous layer (pH 2 obtained) which was subsequently extracted twice with ethyl acetate. The total combined organic layer was dried over magnesium sulfate, filtered and concentrated in vacuo to afford 3-(3- cyclopropylphenoxy)quinoline-4-carboxylic acid.
  • test compounds A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620 nm.
  • Table T1 Compound: 1.1 Pyrenophora teres (Net blotch of barley) Barley leaf segments are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation, the activity of a compound is assessed 4 dpi (days after inoculation) as preventive fungicidal activity.
  • Mycelial fragments of the fungus prepared from a fresh liquid culture were directly mixed into nutrient broth (PDB potato dextrose broth).
  • a DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it.
  • the test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620 nm.

Abstract

Compounds of Formula (I), wherein the substituents are as defined in claim 1, useful as pesticides, especially as fungicides.

Description

MICROBIOCIDAL HETEROBIARYL AMIDE DERIVATIVES
The present invention relates to heterobiaryl amide derivatives, e.g., as active ingredients, which have microbiocidal activity, in particular, fungicidal activity. The invention also relates to agrochemical compositions which comprise at least one of the heterobiaryl amide derivatives, to processes of preparation of these compounds and to uses of the heterobiaryl amide derivatives or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, preferably fungi.
WO 2020/109391 discloses the use of pyridazine (thio)amide derivatives for controlling phytopathogenic microorganisms. WO 2021/233861 discloses the use of azabicyclic(thio)amides derivatives as fungicidal compounds. WO 2021/249995 discloses the use of azabicyclyl-oxadiazole derivatives as fungicidal compounds.
According to the present invention, there is provided a compound of Formula (I):
Figure imgf000002_0001
wherein:
R1 is phenyl substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, Ci-Cs-alkylsulfanyl, Ci-Cs-alkylsulfinyl, C1-C3- alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
R1 is phenyl optionally substituted by 1 , 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, /so-propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or
R1 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, Ci-C2-haloalkyl, C1- C4-alkoxy, Ci-C3-alkylsulfanyl, Ci-C3-alkylsulfinyl, Ci-C3-alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
R1 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is optionally substituted by 1 or 2 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, iso- propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy;
R2 and R3 are each independently selected from hydrogen, and Ci-C4-alkyl; or
R2 and R3, together with the carbon atom to which they are attached, form a Cs-Ce-cycloalkyl group;
R4 and R5 are each independently selected from hydrogen, halogen, cyano, hydroxy, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, and Ci-C4-haloalkoxy; or
R4 and R5, together with the carbon atom to which they are attached, form an oxo or a C3-C6- cycloalkyl group;
R6 is phenyl substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, Ci-Cs-alkylsulfanyl, Ci-C3-alkylsulfinyl, C1-C3- alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
R6 is phenyl optionally substituted by 1 , 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, /so-propyloxy, te/Y-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or
R6 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is substituted by a single substituent selected from hydrogen, hydroxyl, halogen, mercapto, amino, cyano, Ci-C4-alkyl, C1-C2- haloalkyl, Ci-C4-alkoxy, Ci-C3-alkylsulfanyl, Ci-C3-alkylsulfinyl, Ci-C3-alkylsulfonyl, Ci-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, Cs-Ce-cycloalkyl, and Cs-Ce-cycloalkyloxy; or
R6 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1 , 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is optionally substituted by 1 , 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, /so-propyloxy, te/Y-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy;
Y1, Y2, Y3, and Y4 are each independently selected from N and CR7, with the proviso that at least two of Y1, Y2, Y3, and Y4 are selected from N and CH;
R7 is independently selected from hydrogen, halogen, cyano, hydroxy, mercapto, Ci-Cs-alkyl, C1- Cs-alkoxy, Ci-Cs-haloalkyl, Ci-Cs-haloalkoxy, Ci-Cs-alkylsulfonyl, C2-C3-alkynyl, and C3-C4-cycloalkyl;
Z1 is N or CR8, wherein R8 is selected from hydrogen, halogen, cyano, hydroxy, Ci-Cs-alkyl, C1- Cs-alkoxy, Ci-Cs-haloalkyl, Ci-Cs-haloalkoxy, Ci-Cs-alkylsulfonyl, C2-C3-alkenyl, C2-C3-alkynyl, and C3- C4-cycloalkyl; or an agrochemically acceptable salt, stereoisomer, enantiomer, and N-oxide of the compound of formula (I).
Surprisingly, it has been found that the novel compounds of Formula (I) have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi. According to a second aspect of the invention, there is provided an agrochemical composition comprising a fungicidally effective amount of a compound of Formula (I). Such an agricultural composition may further comprise at least one additional active ingredient and/or an agrochemically- acceptable diluent or carrier.
According to a third aspect of the invention, there is provided a method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a fungicidally effective amount of a compound of Formula (I), or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
According to a fourth aspect of the invention, there is provided the use of a compound of Formula (I) as a fungicide. According to this particular aspect of the invention, the use may exclude methods for the treatment of the human or animal body by surgery or therapy.
As used herein, the term “hydroxyl” or “hydroxy” means an -OH group.
As used herein, the term “mercapto” means an -SH group.
As used herein, the term “cyano” means a -CN group.
As used herein, amino means an -NH2 group.
As used herein, nitro means an -NO2 group.
As used herein, oxo means an =O group (eg, as in a carbonyl (C=O) group).
As used herein, the term "halogen" or “halo” refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo), preferably fluorine, chlorine or bromine.
As used herein, the term "Ci-4alkyl" refers to a straight or branched hydrocarbon chain radical consisting solely of carbon and hydrogen atoms, containing no unsaturation, having from one to four carbon atoms, and which is attached to the rest of the molecule by a single bond. Ci-salkyl should be construed accordingly. Examples of Ci-4alkyl include, but are not limited to, methyl, ethyl, /so-propyl.
As used herein, the term "C2-3alkenyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond that may be of either the (E) or (Z) configuration, having two or three carbon atoms, which is attached to the rest of the molecule by a single bond. Examples of Cs salkenyl include, but are not limited to, vinyl (ethenyl), prop-1 -enyl and allyl (prop-2-enyl).
As used herein, the term "Cs-shaloalkenyl" refers to a Cs salkenyl group as defined above substituted by one or more of the same or different halogen atoms.
As used herein, the term "C2-3alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having from two or three carbon atoms, and which is attached to the rest of the molecule by a single bond. Examples of C2-3alkynyl include, but are not limited to, ethynyl, prop-1-ynyl and propargyl (prop-2-ynyl).
As used herein, the term "Ci-3alkoxy" refers to a radical of the formula RaO- where Ra is a Cisalkyl radical as generally defined above. Examples of Ci-salkoxy include, but are not limited to, methoxy, ethoxy and /so-propoxy.
As used herein, the term "Ci-4haloalkyl" refers to a Ci^alkyl radical as generally defined above substituted by one or more of the same or different halogen atoms. Examples of Ci-4haloalkyl include, but are not limited to fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl and 2,2,2-trifluoroethyl. As used herein, the term "C1-3fluoroalkyl" refers to a C1-3alkyl radical as generally defined above substituted by one or more fluorine atoms. Examples of C1-3fluoroalkyl include, but are not limited to difluoromethyl and trifluoromethyl. As used herein, the term "C1-3fluoroalkoxy" refers to a C1-3alkoxy radical as generally defined above substituted by one or more fluorine atoms. Examples of C1-3fluoroalkoxy include, but are not limited to trifluoromethoxy. As used herein, the term "C3-4cycloalkyl" refers to a stable, monocyclic ring radical which is saturated and contains 3 or 4 carbon atoms. As used herein, the term “C1-3alkylsulfanyl” refers to a radical of the formula -SRa wherein Ra is a C1-3alkyl radical as generally defined above. As used herein, the term “C1-3alkylsulfonyl” refers to a radical of the formula -S(O)2Ra wherein Ra is a C1-3alkyl radical as generally defined above. The term “heteroaryl” as used herein refers to a 5- or 6-membered aromatic monocyclic ring having 1, 2 or 3 heteroatoms independently selected from N, O and S. Examples are heteroaryls J-1 to J-31 shown in Table J below. Table J: Heteroaryl J-1 to J-31:
Figure imgf000005_0001
Figure imgf000006_0001
As used herein, the expression “a group optionally substituted by 1 , 2 or 3 substituents” means that the group may be unsusbstituted, or that one, two or three hydrogen atoms of the group are replaced with a susbstituent.
As used herein, the expression “1 , 2 or 3 substituents each independently selected from” or “1 , 2 or 3 heteroatoms each independently selected from” means that the substituents or heteroatoms, as the case may be, may be all the same, all different from each other, or, when 3 substituents or heteroatoms are considered, that two of them are the same and the third is different from the former two. For instance, in a 5- or 6-membered monocyclic heteroaryl ring comprising 2 or 3 heteroatoms each independently selected from N, O and S, the heteroatoms may be all the same, for example only nitrogen atoms, or different, for instance one or two nitrogen atoms and one oxgen atom, or one or two nitrogen atom and one sulfur atom. Examples of heteroaryl rings are shown in Table J above, with heteroaryls J-1 to J-31 .
The presence of one or more possible asymmetric carbon atoms in a compound of Formula (I) means that the compounds may occur in chiral isomeric forms, i.e., enantiomeric or diastereomeric forms. Also, atropisomers may occur as a result of restricted rotation about a single bond. Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of Formula (I). Likewise, Formula (I) is intended to include all possible tautomers (including lactam-lactim tautomerism and ketoenol tautomerism) where present. The present invention includes all possible tautomeric forms for a compound of Formula (I).
In each case, the compounds of Formula (I) according to the invention are in free form, in oxidized form as an N-oxide, in covalently hydrated form, or in salt form, e.g., an agronomically usable or agrochemically acceptable salt form.
N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991.
The following lists provide definitions, including preferred definitions, for Y1, Y2, Y3, Y4, Z1, R1, R2, R3, R4, R5, R6, R7, and R8 with reference to the compounds of Formula (I) of the present invention. For any one of these substituents, any of the definitions given below may be combined with any definition of any other substituent given below or elsewhere in this document.
In an embodiment,
A. Y1, Y2, Y3, and Y4 are each independently selected from N and CR7, with the proviso that at least two of Y1, Y2, Y3, and Y4 are selected from N and CH; and Z1 is N; or
B. Y1, Y2, Y3, and Y4 are each independently selected from N and CR7, with the proviso that at least two of Y1, Y2, Y3, and Y4 are selected from N and CH; and Z1 is CR8; or
C. Y1, Y2, Y3, and Y4 are each independently selected from N and CR7, with the proviso that at least two of Y1, Y2, Y3, and Y4 are selected from N and CH; and Z1 is CH; or D. one of Y1, Y2, Y3, and Y4 is N, another one of Y1, Y2, Y3, and Y4 is CH; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is N; or E. two of Y1, Y2, Y3, and Y4 are N; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is N; or F. two of Y1, Y2, Y3, and Y4 are CH; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is N; or G. one of Y1, Y2, Y3, and Y4 is N; another one of Y1, Y2, Y3, and Y4 is CH; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is CR8; or H. two of Y1, Y2, Y3, and Y4 are N; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is CR8; or I. two of Y1, Y2, Y3, and Y4 are CH; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is CR8; or J. one of Y1, Y2, Y3, and Y4 is N; another one of Y1, Y2, Y3, and Y4 is CH; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is CH; or K. two of Y1, Y2, Y3, and Y4 are N; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is CH; or L. two of Y1, Y2, Y3, and Y4 are CH; the other two of Y1, Y2, Y3, and Y4 are CR7; and Z1 is CH. In embodiments where Y1, Y2, Y3, or Y4 are CR7, R7 is selected from: A. hydrogen, halogen, cyano, hydroxy, mercapto, C1-C3-alkyl, C1-C3-alkoxy, C1-C3-haloalkyl, C1-C3- haloalkoxy, C1-C3-alkylsulfonyl, C2-C3-alkynyl, and C3-C4-cycloalkyl; or B. hydrogen, halogen, cyano, C1-C3-alkyl, C1-C3-alkoxy, C1-C3-haloalkyl, C1-C3-haloalkoxy, C1-C3- alkylsulfonyl, C2-C3-alkynyl, and C3-C4-cycloalkyl; or C. hydrogen, halogen, cyano, methyl, ethyl, methoxy, ethoxy, C1-C2-haloalkyl, C1-C2-haloalkoxy, methylsulfonyl, propargyl, cyclopropyl, and cyclobutyl; or D. hydrogen, halogen, methyl, trifluoromethyl, methoxy, methylsulfonyl, difluoromethoxy, ethynyl, and cyclopropyl; or E. hydrogen, fluoro, chloro, bromo, methyl, trifluoromethyl, methoxy, difluoromethoxy, and propargyl; or F. hydrogen, fluoro, chloro, and methyl; or G. hydrogen. In embodiments where Z1 is CR8, R8 is selected from: A. hydrogen, halogen, cyano, hydroxy, C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C1-C3-alkylsulfonyl, C2-C3-alkenyl, C2-C3-alkynyl, and C3-C4-cycloalkyl; or B. hydrogen, halogen, cyano, hydroxy, C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, C2-C3-alkenyl, C2-C3-alkynyl, and C3-C4-cycloalkyl; or C. hydrogen, halogen, cyano, hydroxy, C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, C1-C3-haloalkoxy, and C3-C4-cycloalkyl; or D. hydrogen, halogen, cyano, hydroxy, methyl, trifluoromethyl, difluoromethyl, methoxy, difluoroalkoxy, and cyclopropyl; or E. hydrogen, fluoro, chloro, bromo, cyano, hydroxy, methyl, trifluoromethyl, difluoromethyl, and cyclopropyl; or F. hydrogen, fluoro, chloro, cyano, hydroxy, and methyl; or G. hydrogen, fluoro, and chloro; or H. hydrogen. In preferred embodiments of compounds of formula (I), the heterobiaryl moiety formed with Y1, Y2, Y3, Y4, Z1 is selected from the groups (Ia) to (Iv) shown in Table L, where R7 has the same meaning as given above for compounds of the formula (I), m equals 0 or 1, and where the staggered lines represent the points of attachment of the heterobiaryl moiety to the remainder of the compound of formula (I): Table L: Heterobiaryl (Ia) to (Iv)
Figure imgf000008_0001
As shown in Table L, in preferred embodiments of compounds of formula (I), Z1 is CH (i.e. groups Ia, Ib, Ic, Id, Ie, If, Ig, Ih, Ii, Ij and Ik in Table L), or Z1 is N (i.e. groups Il, Im, In, Io, Ip, Iq, Ir, Is, It, Iu and Iv in Table L). As also shown in Table L, in preferred embodiments of compounds of formula (I): A. Y1, Y2, Y3, and Y4 are CH or CR7, with the proviso that not more than one is CR7 (i.e. groups Ia and Il in Table L, where m = 0 or 1); or B. Y1, Y2, Y3, and Y4 are CH (i.e. groups Ia and Il in Table L, where m = 0); or C. one of Y1, Y2, Y3, and Y4 is N, and the other three are CH or CR7, with the proviso that not more than one is CR7 (i.e. groups Ib, Ic, Id, Ie, Im, In, Io, and Ip in Table L, where m = 0 or 1); or D. one of Y1, Y2, Y3, and Y4 is N, and the other three are CH (i.e. groups Ib, Ic, Id, Ie, Im, In, Io, and Ip in Table L, where m = 0); or E. two of Y1, Y2, Y3, and Y4 are N, and the other two are CH or CR7, with the proviso that not more than one is CR7 (i.e. groups If, Ig, Ih, Ii, Ij, Ik, Iq, Ir, Is, It, Iu and Iv in Table L, where m = 0 or 1); or F. two of Y1, Y2, Y3, and Y4 are N, and the other two are CH (i.e. groups If, Ig, Ih, Ii, Ij, Ik, Iq, Ir, Is, It, Iu and Iv in Table L, where m = 0); or G. one or two of Y1, Y2, Y3, and Y4 are N, and the others are CH In preferred embodiments where Y1, Y2, Y3, or Y4 are CR7, m is 0 or 1, and R7 is selected from: A. hydrogen, halogen, methyl, trifluoromethyl, methoxy, methylsulfonyl, difluoromethoxy, ethynyl, and cyclopropyl; or B. hydrogen, fluoro, chloro, bromo, methyl, trifluoromethyl, methoxy, and difluoromethoxy; or C. hydrogen, fluoro, chloro, and methyl; or D. hydrogen. In more preferred embodiments of compounds of formula (I), the heterobiaryl moiety formed with Y1, Y2, Y3, Y4, Z1 is selected from the groups (Ia), (Ib), (Ic), (Id), (Ie), (Ig), (Ih) and (Ii), and m equals 0:
Figure imgf000009_0001
Most preferably, the heterobiaryl moiety formed with Y1, Y2, Y3, Y4, Z1 is group (Ia), i.e. where Y1, Y2, Y3, Y4, and Z1 are CH and m equals 0. In an embodiment, R1 is selected from: A. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2- haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3-alkylsulfonyl, C1-C2- haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkyloxy; or B. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, chloro, fluoro, bromo, mercapto, amino, cyano, methyl, ethyl, vinyl, allyl, 2,2-difluorovinyl, ethynyl, prop-1-ynyl, propargyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or C. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C2-alkyl, C1-C2- fluoroalkyl, C1-C2-alkoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, prop-1-ynyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or D. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, chloro, fluoro, amino, cyano, methyl, ethyl, vinyl, prop-1-ynyl, propargyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or E. phenyl, pyridyl, pyrimidinyl or thienyl, wherein the phenyl, pyridyl, pyrimidinyl or thienyl is optionally substituted by 1 or 2 substituents each independently selected from hydroxyl, chloro, fluoro, amino, cyano, methyl, trifluoromethyl, methoxy, ethoxy, methylsulfanyl, methylsulfinyl, methylsulfonyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or F. phenyl, pyridyl, pyrimidinyl or thienyl, wherein the phenyl, pyridyl, pyrimidinyl or thienyl is substituted by a single substituent selected from hydroxyl, chloro, fluoro, amino, cyano, methyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or G. phenyl, pyridyl, pyrimidinyl or thienyl, wherein the phenyl, pyridyl, pyrimidinyl or thienyl is optionally substituted by 1 or 2 substituents each independently selected from methyl, chloro, fluoro, trifluoromethyl, methylsulfonyl, vinyl, ethynyl, propargyl, cyclopropyl, and cyclopropyloxy; or H. phenyl, pyridyl, pyrimidinyl or thienyl, wherein the phenyl, pyridyl, pyrimidinyl or thienyl is substituted by a single substituent selected from methyl, chloro, fluoro, trifluoromethyl, methoxy, methylsulfonyl, ethynyl, prop-1-ynyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or I. phenyl, 3-methylphenyl, 3-chlorophenyl, 3-cyclopropylphenyl, 3-ethynylphenyl, 3- trifluoromethylphenyl, 3-cyclopropyl-2-fluorophenyl, and 3-pyridyl optionally substituted by methyl, chloro, fluoro, cyano, trifluoromethyl, methylsulfonyl, ethynyl, cyclopropyl, or cyclopropyloxo; or J. phenyl, 3-methylphenyl, 3-chlorophenyl, 3-cyclopropylphenyl, 3-ethynylphenyl, 3- trifluoromethylphenyl, and 3-cyclopropyl-2-fluorophenyl; or K. phenyl, 3-cyclopropylphenyl, 3-trifluoromethylphenyl, and 3-pyridyl optionally substituted by methyl, chloro, cyano; or L. phenyl, 3-cyclopropylphenyl, 3-pyridyl, 5-chloro-3-pyridyl, 5-methyl-3-pyridyl, and 5-cyano-3-pyridyl; or M. 3-cyclopropylphenyl, 3-pyridyl, 5-chloro-3-pyridyl, 5-methyl-3-pyridyl, and 5-cyano-3-pyridyl; or N. phenyl and 3-cyclopropylphenyl; or O. phenyl; or P. 3-cyclopropylphenyl; or Q. 3-trifluoromethylphenyl;or R. 3-pyridyl; or S. 5-chloro-3-pyridyl; or T. 5-methyl-3-pyridyl; or U. 5-cyano-3-pyridyl. In an embodiment, R2 and R3 are as follows: A. R2 and R3 are each independently selected from hydrogen and C1-C3-alkyl; or B. R2 is C1-C3-alkyl, and R3 is hydrogen or C1-C3-alkyl different from R2; or C. R2 and R3 are each independently selected from hydrogen, methyl, ethyl, propyl, and methylethyl; or D. R2 is methyl, ethyl, propyl, and methylethyl, and R3 is hydrogen; or E. R2 is methyl or ethyl, and R3 is hydrogen; or F. R2 is methyl, and R3 is hydrogen; or G. R2 and R3 are each independently selected from hydrogen and methyl; or H. hydrogen. Preferably, R2 and R3 are hydrogen. In an embodiment, R4 and R5 are as follows: A. R4 and R5 are each independently selected from hydrogen, halogen, C1-C3-alkyl, C1-C3-haloalkyl, C1-C3-alkoxy, and C1-C3-haloalkoxy; or R4 and R5 together with the carbon atom to which they are attached, form an oxo, cyclopropyl, or cyclobutyl group; or B. R4 and R5 are each independently selected from hydrogen, fluoro, chloro, bromo, methyl, ethyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, difluoromethoxy; or R4 and R5 together with the carbon atom to which they are attached, form a cyclopropyl group; or C. R4 and R5 are each independently selected from hydrogen, fluoro, chloro, methyl, ethyl, and methoxy; or R4 and R5 together with the carbon atom to which they are attached, form an oxo or a cyclopropyl group; or D. R4 and R5 are each independently selected from hydrogen, fluoro, and methyl; or R4 and R5 together with the carbon atom to which they are attached, form a cyclopropyl group; or E. R4 and R5 are each independently selected from hydrogen and fluoro; or R4 and R5 together with the carbon atom to which they are attached, form a cyclopropyl group; or F. R4 and R5 are each independently selected from hydrogen and fluoro; or G. R4 and R5 are differently selected from hydrogen and fluoro. In an embodiment, R6 is selected from: A. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2- haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3-alkylsulfonyl, C1-C2- haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, and C3-C6- cycloalkyloxy; or B. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, chloro, fluoro, bromo, mercapto, amino, cyano, methyl, ethyl, vinyl, allyl, 2,2-difluorovinyl, ethynyl, prop-1-ynyl, propargyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or C. phenyl or a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, wherein the phenyl or heteroaryl ring is substituted by a single substituent selected from hydroxyl, chloro, fluoro, bromo, cyano, methyl, ethyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, methylsulfinyl, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, prop-1-ynyl, propargyl, cyclopropyl, cyclobutyl, and cyclopropyloxy; or D. phenyl, 2-pyridyl, 3-pyridyl and 4-pyridyl, wherein the phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl is optionally substituted by one or two substituents each independently selected from chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, methoxy, methylsulfonyl, difluoromethoxy, vinyl, allyl, and ethynyl; or E. phenyl, 4-tolyl, 2,4-dichlorophenyl, 2-pyridyl, 2,4-difluorophenyl, 4-pyridyl, 2,4-dibromophenyl, 5- bromo-2-pyridyl, 2,4-dimethylphenyl, 3,5-dichloro-2-pyridyl, 2-chloro-4-fluorophenyl, 3-chloro-2- pyridyl, 2-chloro-4-bromophenyl, 3-chloro-5-methyl-2-pyridyl, 2-chloro-4-methylphenyl, 6-chloro-3- pyridyl, 2-chlorophenyl, and 4,6-dichloro-3-pyridyl. Preferably, the compound according to Formula (I) is compound 1.1 listed in Table T1 (below). The compounds of the present invention may be enantiomers of the compound of Formula (I) as represented by Formula (I-1) or Formula (I-2) or Formula (I-3) or Formula (I-4), wherein R2 and R3 are different substituents and/or wherein R4 and R5 are different substituents.
Figure imgf000012_0001
(I-1) (I-2)
Figure imgf000013_0001
The compounds of formula (I) according to the invention can be made as shown in the following schemes 1 to 10, wherein R1, R2, R3, R4, R5, R6, R7, R8, Y1, Y2, Y3, Y4 and Z1 are as defined for a compound of formula (I), unless otherwise stated. The compounds of formula (I) are can be obtained by an amide-coupling transformation with compounds of formula (II), wherein X1 is OH and amine compounds of formula (III) by activating the carboxylic acid function of the compounds of formula (II), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as an acyl chloride group for example by using (COCl)2 or SOCl2, prior to treatment with the compounds of formula (III), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane, tetrahydrofuran, 2-methyl-tetrahydrofuran, EtOAc and the like), preferably at temperatures between 25°C and 60°C, and optionally in the presence of a base such as triethylamine, N,N- diisopropylethylamine or dimethylaminopyridine. For compounds of formula (II) wherein X1 is iodide the acyl chloride intermediate is treated with potassium iodide, in a suitable solvent such as acetonitrile and the resultant acyl iodides are then treated with compounds of formula (III), optionally in the presence of a base, to give compounds of formula (I). For related examples, see: Org. Lett. (2013), 15, 702–705. Alternatively, such amide couplings can be achieved using compounds of formula (II), wherein X1 is OH, with amines of formula (III), using a suitable activating agent such as 1-propanephosphonic acid cyclic anhydride (T3P) in suitable solvent (e.g., acetonitrile), optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). For related examples, see Chem. Soc. Rev. (2009), 38, 606 and Chem. Soc. Rev. (2011), 40, 5084. Furthermore, compounds of formula (I), can be obtained by an amide-coupling transformation with compounds of formula (II), wherein X1 is C1-C4alkoxy, and amine compounds of formula (III) in the presence of a suitable lewis acid, such as methylaluminium dichloride, trimethylaluminium, or DABAL- Me3 (an adduct of trimethylaluminum and DABCO®) in the presence of compounds of formula (III) in a suitable solvent such as toluene and at temperatures between 20°C and 90°C. For related examples, see Tet. Lett. (1977), 4171-4174 and Tet. Lett. (2006), 5767-5769, Synth. Commun. (1982) 12, 989- 993. This is shown in Scheme 1.
Figure imgf000014_0001
(II) (III) (I) Scheme 1 Compounds of formula (I), are prepared from reacting nucleophilic compounds of formula (IV) with electrophilic compounds of formula (V), wherein X2 is a suitable leaving group such as fluoro, chloro, bromo, iodo, [and when Z1 is CR8, optionally BF3K, B(OH)2 or B(pinacol)], in the presence of base (e.g. KO-t-Bu, K3PO4, K2CO3, triethylamine, or Cs2CO3), in a suitable solvent (e.g. N-methylpyrrolidone, dimethylacetamide, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran, sulfolane, or dimethylsulfoxide) at temperatures between 25°C and reflux, optionally in the presence of a metal catalyst complex (e.g. Cu or Pd). For related examples, see Eur. J. Org. Chem. (2011), 18, 3353; J. Org. Chem. (2009), 74, 7951; Tetrahedron Lett. (2012), 53, 5318; WO 2008/110313, WO 2012/136604, Journal of Heterocyclic Chemistry (2004), 41, 987-989, Modern Nucleophilic Aromatic Substitution, Wiley-VCH, Weinheim, 2013. Compounds of formula (IV) are either known or commercially available. This is shown in Scheme 2.
Figure imgf000014_0002
Scheme 2 Compounds of formula (II), wherein X1 is OH C1-C4-alkoxy, namely compounds of are prepared from reacting nucleophilic compounds of formula (IV) with electrophilic compounds of formula (VI), wherein X1 is OH or C1-C4-alkoxy and X2 is a suitable leaving group such as NO2, fluoro, chloro, bromo, iodo, [and when Z1 is CR8, optionally BF3K, B(OH)2 or B(pinacol)], in the presence of base (e.g. KO-t- Bu, K3PO4, K2CO3, triethylamine, or Cs2CO3, in a suitable solvent (e.g. N-methylpyrrolidone, dimethylacetamide, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran, sulfolane, dimethylsulfoxide) at temperatures between 25°C and reflux, optionally in the presence of a metal catalyst complex (e.g. Cu or Pd). For related examples, see: Eur. J. Org. Chem. (2011), 18, 3353; J. Org. Chem. (2009), 74, 7951; Tetrahedron Lett. (2012), 53, 5318; WO 2008/110313, WO 2012/136604, Journal of Heterocyclic Chemistry (2004), 41, 987-989, Modern Nucleophilic Aromatic Substitution, Wiley-VCH, Weinheim, 2013. Additionally, compounds of formula (II), wherein X1 = OH, can be prepared via hydrolysis of compounds of formula (II), wherein X = C1-C4-alkoxy, by treatment with a base (e.g., NaOH, LiOH) in a suitable solvent mixture (e.g., tetrahydrofuran/water) at temperatures between 20°C and 60°C. For related examples, see: Bioorg. Med. Chem. Lett. (2008), 18, 5115. Compounds of formula (VI) are either known or commercially available. This is shown in Scheme 3.
Figure imgf000015_0001
Scheme 3 Compounds of formula (V), wherein X2 is nitro, halogen, or OH, can be obtained by an amide coupling transformation with compounds of formula (VI), wherein X1 is OH and X2 is nitro, halogen or OH, and amine compounds of formula (III) by activating the carboxylic acid function of the compounds of formula (VI), a process that usually takes place by converting the -OH of the carboxylic acid into a good leaving group, such as a chloride group, for example by using (COCl)2 or SOCl2, prior to treatment with the compounds of formula (III), preferably in a suitable solvent (e.g., N-methylpyrrolidone dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25°C and 60°C, and optionally in the presence of a base such as triethylamine or N,N-diisopropylethylamine; or alternatively under conditions described in the literature for an amide coupling such as 1- propanephosphonic acid cyclic anhydride (T3P) in suitable solvent (e.g., acetonitrile), optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). For related examples, see: Chem. Soc. Rev. (2009), 38, 606 and. Chem. Soc. Rev. (2011), 40, 5084. This is shown in Scheme 4.
Figure imgf000015_0002
Scheme 4 Compounds of formula (II), wherein X1 is OH or C1-C4-alkoxy, are prepared from reacting nucleophilic compounds of formula (VI), wherein X2 is OH and X1 is OH or C1-C4-alkoxy, with electrophilic compounds of formula (X), wherein and E is fluoro, chloro, bromo, iodo, BF3K, B(OH)2 or B(pinacol), in a suitable solvent (e.g. dichloromethane, 1,2-dichloromethane, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran, N-methylpyrrolidone, dimethylacetamide) at temperatures between 40°C and 80°C and using a metal source (e.g. Cu(OAc)2), and preferably in the presence of an oxidant such as O2 or a suitable palladium pre-catalyst, such as RockPhos Pd G3, in the presence of a base (e.g. K3PO4) and suitable solvent (e.g. dimethyl ether or toluene) at temperatures between 20°C and 80°C. For related examples, see: Org. Lett. (2003), 5, 1381; Tetrahedron Lett. (1998), 39, 2933; Tetrahedron Lett. (2003), 44, 3863; and Org. Lett. (2013), 15, 2876. Compounds of formula (X) and compounds of formula (VI) are either known or commercially available. This is shown in Scheme 5.
Figure imgf000016_0001
(X) (VI) (II) Scheme 5 Compounds of formula (I) are prepared from reacting nucleophilic compounds of formula (V), wherein X2 is OH, with electrophilic compounds of formula (X), wherein and E is chloro, bromo, iodo, BF3K, B(OH)2 or B(pinacol), in a suitable solvent (e.g. dichloromethane, 1,2-dichloromethane, acetonitrile, tetrahydrofuran, 2-methyl tetrahydrofuran) at temperatures between 40°C and 80°C and using a metal source (e.g. Cu(OAc)2), optionally in the presence of an oxidant such as O2 or a suitable palladium pre-catalyst, such as RockPhos Pd G3, in the presence of a base (e.g. K3PO4) and in a suitable solvent (e.g.toluene) at temperatures between 20°C and 80°C. For related examples, see: Org. Lett. (2003), 5, 1381; Tetrahedron Lett. (1998), 39, 2933; Tetrahedron Lett. (2003), 44, 3863; and Org. Lett. (2013), 15, 2876. Compounds of formula (X) are either known or commercially available. This is shown in Scheme 6
Figure imgf000016_0002
Compounds of Formula (IX), wherein X1 is C1-C4-alkoxy and X4 is H, C(O)H, C(O)-C1-C4alkyl, or C(O)-C1-C4-alkoxy are known or can be obtained from a compounds of Formula (XI), wherein X3 is bromo or iodo, via palladium-catalyzed di-carbonylation transformation, using a suitable palladium catalyst complex (e.g., PEPPSI™-IPr catalyst or XantPhos-ligated Pd-catalyst pre-cursor), in a carbon monoxide atmosphere (e.g., 1 -20 bars), optionally in the presence of a suitable base (e.g., K2CO3), and in a suitable solvent system (e.g., dioxane/C1-C4alkyl-OH) at temperatures between 25°C and 50°C. For related examples, see: RSC Advances (2014), 4, 48177-48190 and Organic Letters (2009), 11, 1321- 1324. Fang, W. et al Org. Lett. (2013), 15, 3678; Friis, D. et al Org. Lett. (2014), 16, 4296-4299. This reaction is shown in Scheme 7 below.
Figure imgf000017_0001
(XII) (IX) Scheme 7 Alternatively, compounds of Formula (IX), wherein X1 is OH or C1-C4-alkoxy, can be obtained from compounds of Formula (XIII) by heating at temperatures between 25°C and 60°C, optionally in the presence of a suitable base (e.g., triethylamine, K2CO3) and in a suitable solvent (e.g., methanol, ethanol, tert-butanol). For related examples, see: Journal of Organic Chemistry (2019), 84, 7395-7404. This reaction is shown in Scheme 8 below.
Figure imgf000017_0002
(XIII) (IX) Scheme 8 Compounds of Formula (XIV), wherein X1 is OH or C1-C4alkoxy and X2 is nitro, are either known or can be obtained from 2-amino carbonyl compounds of formula (XVI), wherein X1 is OH or C1-C4alkoxy and X4 is H, C(O)H, C(O)C1-C4alkyl, or C(O)-C1-C4alkoxy, via a method involving a modified Friedlander- type condensation with nitro compounds of formula (XV) in presence of a suitable base (e.g., DABCO) in a suitable solvent (e.g., benzene or toluane) optionally followed by addition of an oxidating reagent, such as 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) at temperatures between 25°C and relux. For related examples, see:. J. Chem. Soc. (1950), 395; J. Chem. Soc. (1951), 2992 J. Chem. Soc. (1953), 3914; J. Am. Chem. Soc. (1957), 79, 1502; J. Org. Chem. (2004), 69, 1565-1570. This reaction is shown in Scheme 9 below.
Figure imgf000017_0003
Scheme 9 Compounds of Formula (XVII), wherein X1 is OH and X2 is OH, halogen or nitro, can be obtained from compounds of formula (XVIII), wherein X2 is OH, via an oxidation method using a suitable oxidant, suchs as KMnC or a cobalt(ll) salt and trihydroxyisocyanuric acid (THICA) in a suitable solvent (e.g., acetic acid) at temperatures between 25°C and 200°C. For related examples, see: Can. J. Chem. (1978), 56, 1273; WO2021160470. Compounds of formula (XVIII) are known or can be prepared as described in Bulletin de la Societe Chimique de France (1972), 8, 3198-202 This reaction is shown in Scheme 10 below.
Figure imgf000018_0001
(XVIII) (XVII)
Scheme 10
As already indicated, surprisingly, it has now been found that the compounds of Formula (I) of the present invention have, for practical purposes, a very advantageous level of biological activity for protecting plants against diseases that are caused by fungi.
The compounds of Formula (I) can be used in the agricultural sector and related fields of use, e.g., as active ingredients for controlling plant pests or on non-living materials for the control of spoilage microorganisms or organisms potentially harmful to man. The novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and can be used for protecting numerous cultivated plants. The compounds of Formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later, e.g., from phytopathogenic microorganisms.
The present invention further relates to a method for controlling or preventing infestation of plants or plant propagation material and/or harvested food crops susceptible to microbial attack by treating plants or plant propagation material and/or harvested food crops wherein an effective amount a compound of Formula (I) is applied to the plants, to parts thereof or the locus thereof.
It is also possible to use compounds of Formula (I) as a fungicide. The term “fungicide” as used herein means a compound that controls, modifies, or prevents the growth of fungi. The term “fungicidally effective amount” where used means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all dev/ation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.
It may also be possible to use compounds of Formula (I) as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings, for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of Formula (I) before planting: seed, for example, can be dressed before being sown. The active compounds of Formula (I) can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.
Furthermore, the compounds of Formula (I) can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene management.
In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.
The compounds of Formula (I) are for example, effective against fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses. These fungi and fungal vectors of disease as well as phytopathogenic bacteria and viruses are for example:
Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. inclusing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea, Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae, Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp.Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi- virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp. including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V. inaequalis, Verticillium spp, and Xanthomonas spp.
The compounds of Formula (I) may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.
Within the scope of present invention, target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass, fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.
The term "useful plants" is to be understood as also including useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol- pyrovyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola). Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I® and LibertyLink®.
The term "useful plants" is to be understood as also including useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
Examples of such plants are: YieldGard® (maize variety that expresses a CrylA(b) toxin); YieldGard Rootworm® (maize variety that expresses a CrylllB(bl) toxin); YieldGard Plus® (maize variety that expresses a CrylA(b) and a CrylllB(bl) toxin); Starlink® (maize variety that expresses a Cry9(c) toxin); Herculex I® (maize variety that expresses a CrylF(a2) toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylA(c) toxin); Bollgard I® (cotton variety that expresses a CrylA(c) toxin); Bollgard II® (cotton variety that expresses a CrylA(c) and a CryllA(b) toxin); VIPCOT® (cotton variety that expresses a VIP toxin); NewLeaf® (potato variety that expresses a CrylllA toxin); NatureGard® Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait), Agrisure® RW (corn rootworm trait) and Protecta®.
The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.
Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as 8-endotoxins, e.g. CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.
Further, in the context of the present invention there are to be understood by 8-endotoxins, for example CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810).
Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO93/07278, WO95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.
The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.
The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera). Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylAc toxin); Bollgard I® (cotton variety that expresses a CrylAc toxin); Bollgard II® (cotton variety that expresses a CrylAc and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a CrylAb toxin); NewLeaf® (potato variety that expresses a Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta®.
Further examples of such transgenic crops are:
1 . Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated CrylAb toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.
3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.
4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.
5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/ES/96/02.
6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1 F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.
7. NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 x MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1 Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.
The term “locus” as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.
The term “plants” refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.
The term “plant propagation material” is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There can be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants can be protected before transplantation by a total or partial treatment by immersion. Preferably “plant propagation material” is understood to denote seeds.
The compounds of Formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently Formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
Suitable carriers and adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890.
Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include fuller’s earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent. Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.
Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required. Typical carriers for granular Formulations include sand, fuller’s earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound. Granular formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins.
Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.
Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter. The enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound. Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores. Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.
Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents. Pressurised sprayers, wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.
Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.
Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1 ,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethyl formamide, dimethyl sulfoxide, 1 ,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethyl hexanol, ethylene carbonate, 1 ,1 ,1-trichloroethane, 2-heptanone, alpha pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropyl benzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octyl amine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerine and N-methyl-2-pyrrolidinone. Water is generally the carrier of choice for the dilution of concentrates.
Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller’s earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin.
A broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1 % to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes. Typical surface active agents include salts of alkyl sulfates, such as diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as nonylphenol-C.sub. 18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub. 16 ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryl trimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters.
Other adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti-foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.
In addition, further, other biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.
Pesticidal agents are referred to herein using their common name are known, for example, from "The Pesticide Manual", 15th Ed., British Crop Protection Council 2009.
In addition, the compositions of the invention may also be applied with one or more systemically acquired resistance inducers (“SAR” inducer). SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.
The compounds of Formula (I) are normally used in the form of agrochemical compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non- selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
The compounds of Formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of Formula (I) or of at least one preferred individual compound as defined herein, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.
The invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound Formula (I) an agriculturally acceptable carrier and optionally an adjuvant. An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art. Preferably said composition may comprise at least one or more pesticidally-active compounds, for example an additional fungicidal active ingredient in addition to the compound of Formula (I).
The compound of Formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate. An additional active ingredient may, in some cases, result in unexpected synergistic activities.
Examples of suitable additional active ingredients include the following: acycloamino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenical fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fungicides, organophosphorous fungicides, organotin fungicides, oxathiin fungicides, oxazole fungicides, phenylsulfamide fungicides, polysulfide fungicides, pyrazole fungicides, pyridine fungicides, pyrimidine fungicides, pyrrole fungicides, quaternary ammonium fungicides, quinoline fungicides, quinone fungicides, quinoxaline fungicides, strobilurin fungicides, sulfonanilide fungicides, thiadiazole fungicides, thiazole fungicides, thiazolidine fungicides, thiocarbamate fungicides, thiophene fungicides, triazine fungicides, triazole fungicides, triazolopyrimidine fungicides, urea fungicides, valinamide fungicides, and zinc fungicides.
Specific examples of suitable additional active ingredients also include a compound selected from the group of substances consisting of petroleum oils, 1 ,1-bis(4-chlorophenyl)-2-ethoxyethanol, 2,4- dichlorophenyl benzenesulfonate, 2-fluoro-N-methyl-N-1 -naphthylacetamide, 4-chlorophenyl phenyl sulfone, acetoprole, aldoxycarb, amidithion, amidothioate, amiton, amiton hydrogen oxalate, amitraz, aramite, arsenous oxide, azobenzene, azothoate, benomyl, benoxafos, benzyl benzoate, bixafen, brofenvalerate, bromocyclen, bromophos, bromopropylate, buprofezin, butocarboxim, butoxycarboxim, butylpyridaben, calcium polysulfide, camphechlor, carbanolate, carbophenothion, cymiazole, chino- methionat, chlorbenside, chlordimeform, chlordimeform hydrochloride, chlorfenethol, chlorfenson, chlorfensulfide, chlorobenzilate, chloromebuform, chloromethiuron, chloropropylate, chlorthiophos, cinerin I, cinerin II, cinerins, closantel, coumaphos, crotamiton, crotoxyphos, cufraneb, cyanthoate, DCPM, DDT, demephion, demephion-O, demephion-S, demeton-methyl, demeton-O, demeton-O- methyl, demeton-S, demeton-S-methyl, demeton-S-methylsulfon, dichlofluanid, dichlorvos, dicliphos, dienochlor, dimefox, dinex, dinex-diclexine, dinocap-4, dinocap-6, dinocton, dinopenton, dinosulfon, dinoterbon, dioxathion, diphenyl sulfone, disulfiram, DNOC, dofenapyn, doramectin, endothion, eprinomectin, ethoate-methyl, etrimfos, fenazaflor, fenbutatin oxide, fenothiocarb, fenpyrad, fen- pyroximate, fenpyrazamine, fenson, fentrifanil, flubenzimine, flucycloxuron, fluenetil, fluorbenside, FMC 1137, formetanate, formetanate hydrochloride, formparanate, gamma-HCH, glyodin, halfenprox, hexadecyl cyclopropanecarboxylate, isocarbophos, jasmolin I, jasmolin II, jodfenphos, lindane, malonoben, mecarbam, mephosfolan, mesulfen, methacrifos, methyl bromide, metolcarb, mexacarbate, milbemycin oxime, mipafox, monocrotophos, morphothion, moxidectin, naled, 4-chloro-2-(2-chloro-2- methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one, nifluridide, nikkomycins, nitrilacarb, nitrilacarb 1 :1 zinc chloride complex, omethoate, oxydeprofos, oxydisulfoton, pp'-DDT, parathion, permethrin, phenkapton, phosalone, phosfolan, phosphamidon, polychloroterpenes, polynactins, proclonol, promacyl, propoxur, prothidathion, prothoate, pyrethrin I, pyrethrin II, pyrethrins, pyridaphenthion, pyrimitate, quinalphos, quintiofos, R-1492, phosglycin, rotenone, schradan, sebufos, selamectin, sophamide, SSI-121 , sulfiram, sulfluramid, sulfotep, sulfur, diflovidazin, tau-fluvalinate, TEPP, terbam, tetradifon, tetrasul, thiafenox, thiocarboxime, thiofanox, thiometon, thioquinox, thuringiensin, triamiphos, triarathene, triazophos, triazuron, trifenofos, trinactin, vamidothion, vaniliprole, bethoxazin, copper dioctanoate, copper sulfate, cybutryne, dichlone, dichlorophen, endothal, fentin, hydrated lime, nabam, quinoclamine, quinonamid, simazine, triphenyltin acetate, triphenyltin hydroxide, crufomate, piperazine, thiophanate, chloralose, fenthion, pyridin-4-amine, strychnine, 1-hydroxy-1 H- pyridine-2-thione, 4-(quinoxalin-2-ylamino)benzenesulfonamide, 8-hydroxyquinoline sulfate, bronopol, copper hydroxide, cresol, dipyrithione, dodicin, fenaminosulf, formaldehyde, hydrargaphen, kasugamycin, kasugamycin hydrochloride hydrate, nickel bis(dimethyldithiocarbamate), nitrapyrin, octhilinone, oxolinic acid, oxytetracycline, potassium hydroxyquinoline sulfate, probenazole, streptomycin, streptomycin sesquisulfate, tecloftalam, thiomersal, Adoxophyes orana GV, Agrobacterium radiobacter, Amblyseius spp., Anagrapha falcifera NPV, Anagrus atomus, Aphelinus abdominalis, Aphidius colemani, Aphidoletes aphidimyza, Autographa californica NPV, Bacillus sphaericus Neide, Beauveria brongniartii, Chrysoperla carnea, Cryptolaemus montrouzieri, Cydia pomonella GV, Dacnusa sibirica, Diglyphus isaea, Encarsia formosa, Eretmocerus eremicus, Heterorhabditis bacteriophora and H. megidis, Hippodamia convergens, Leptomastix dactylopii, Macrolophus caliginosus, Mamestra brassicae NPV, Metaphycus helvolus, Metarhizium anisopliae var. acridum, Metarhizium anisopliae var. anisopliae, Neodiprion sertifer NPV and N. lecontei NPV, Orius spp., Paecilomyces fumosoroseus, Phytoseiulus persimilis, Steinernema bibionis, Steinernema carpocapsae, Steinernema feltiae, Steinernema glaseri, Steinernema riobrave, Steinernema riobravis, Steinernema scapterisci, Steinernema spp., Trichogramma spp., Typhlodromus occidentalis, Verticillium lecanii, apholate, bisazir, busulfan, dimatif, hemel, hempa, metepa, methiotepa, methyl apholate, morzid, penfluron, tepa, thiohempa, thiotepa, tretamine, uredepa, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol, (E)-tridec-4-en-1-yl acetate, (E)-6-methylhept-2-en-4-ol, (E,Z)-tetradeca-4,10- dien-1-yl acetate, (Z)-dodec-7-en-1-yl acetate, (Z)-hexadec-11-enal, (Z)-hexadec-l 1-en-1-yl acetate, (Z)-hexadec-13-en-11-yn-1-yl acetate, (Z)-icos-13-en-10-one, (Z)-tetradec-7-en-1-al, (Z)-tetradec-9-en- 1-ol, (Z)-tetradec-9-en-1-yl acetate, (7E,9Z)-dodeca-7,9-dien-1-yl acetate, (9Z,11 E)-tetradeca-9,11- dien-1-yl acetate, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate, 14-methyloctadec-1-ene, 4-methylnonan- 5-ol with 4-methylnonan-5-one, alpha-multistriatin, brevicomin, codlelure, codlemone, cuelure, disparlure, dodec-8-en-1-yl acetate, dodec-9-en-1-yl acetate, dodeca-8, 10-dien-1-yl acetate, dominicalure, ethyl 4-methyloctanoate, eugenol, frontalin, grandlure, grandlure I, grandlure II, grandlure III, grandlure IV, hexalure, ipsdienol, ipsenol, japonilure, lineatin, litlure, looplure, medlure, megatomoic acid, methyl eugenol, muscalure, octadeca-2,13-dien-1-yl acetate, octadeca-3,13-dien-1-yl acetate, orfralure, oryctalure, ostramone, siglure, sordidin, sulcatol, tetradec-11-en-1-yl acetate, trimedlure, trimedlure A, trimedlure Bi, trimedlure B2, trimedlure C, trunc-call, 2-(octylthio)ethanol, butopyronoxyl, butoxy(polypropylene glycol), dibutyl adipate, dibutyl phthalate, dibutyl succinate, diethyltoluamide, dimethyl carbate, dimethyl phthalate, ethyl hexanediol, hexamide, methoquin-butyl, methylneodecanamide, oxamate, picaridin, 1-dichloro-1 -nitroethane, 1 ,1-dichloro-2,2-bis(4- ethylphenyl)ethane, 1 ,2-dichloropropane with 1 ,3-dichloropropene, 1-bromo-2-chloroethane, 2,2,2- trichloro-1-(3,4-dichlorophenyl)ethyl acetate, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate, 2- (1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate, 2-(2-butoxyethoxy)ethyl thiocyanate, 2-(4,5-dimethyl-1 ,3- dioxolan-2-yl)phenyl methylcarbamate, 2-(4-chloro-3,5-xylyloxy)ethanol, 2-chlorovinyl diethyl phosphate, 2-imidazolidone, 2-isovalerylindan-1 ,3-dione, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate, 2-thiocyanatoethyl laurate, 3-bromo-1 -chloroprop-1 -ene, 3-methyl-1-phenylpyrazol- 5-yl dimethylcarbamate, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate, 5,5-dimethyl-3- oxocyclohex-1-enyl dimethylcarbamate, acethion, acrylonitrile, aldrin, allosamidin, allyxycarb, alphaecdysone, aluminium phosphide, aminocarb, anabasine, athidathion, azamethiphos, Bacillus thuringiensis delta endotoxins, barium hexafluorosilicate, barium polysulfide, barthrin, Bayer 22/190, Bayer 22408, beta-cyfluthrin, beta-cypermethrin, bioethanomethrin, biopermethrin, bis(2-chloroethyl) ether, borax, bromfenvinfos, bromo-DDT, bufencarb, butacarb, butathiofos, butonate, calcium arsenate, calcium cyanide, carbon disulfide, carbon tetrachloride, cartap hydrochloride, cevadine, chlorbicyclen, chlordane, chlordecone, chloroform, chloropicrin, chlorphoxim, chlorprazophos, cis-resmethrin, cismethrin, clocythrin, copper acetoarsenite, copper arsenate, copper oleate, coumithoate, cryolite, CS 708, cyanofenphos, cyanophos, cyclethrin, cythioate, d-tetramethrin, DAEP, dazomet, decarbofuran, diamidafos, dicapthon, dichlofenthion, dicresyl, dicyclanil, dieldrin, diethyl 5-methylpyrazol-3-yl phosphate, dilor, dimefluthrin, dimetan, dimethrin, dimethylvinphos, dimetilan, dinoprop, dinosam, dinoseb, diofenolan, dioxabenzofos, dithicrofos, DSP, ecdysterone, El 1642, EMPC, EPBP, etaphos, ethiofencarb, ethyl formate, ethylene dibromide, ethylene dichloride, ethylene oxide, EXD, fenchlorphos, fenethacarb, fenitrothion, fenoxacrim, fenpirithrin, fensulfothion, fenthion-ethyl, flucofuron, fosmethilan, fospirate, fosthietan, furathiocarb, furethrin, guazatine, guazatine acetates, sodium tetrathiocarbonate, halfenprox, HCH, HEOD, heptachlor, heterophos, HHDN, hydrogen cyanide, hyquincarb, IPSP, isazofos, isobenzan, isodrin, isofenphos, isolane, isoprothiolane, isoxathion, juvenile hormone I, juvenile hormone II, juvenile hormone III, kelevan, kinoprene, lead arsenate, leptophos, lirimfos, lythidathion, m- cumenyl methylcarbamate, magnesium phosphide, mazidox, mecarphon, menazon, mercurous chloride, mesulfenfos, metam, metam-potassium, metam-sodium, methanesulfonyl fluoride, methocrotophos, methoprene, methothrin, methoxychlor, methyl isothiocyanate, methylchloroform, methylene chloride, metoxadiazone, mirex, naftalofos, naphthalene, NC-170, nicotine, nicotine sulfate, nithiazine, nornicotine, 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate, O,O-diethyl 0-4- methyl-2-oxo-2H-chromen-7-yl phosphorothioate, O,O-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate, O,O,O',O'-tetrapropyl dithiopyrophosphate, oleic acid, para-dichlorobenzene, parathion-methyl, pentachlorophenol, pentachlorophenyl laurate, PH 60-38, phenkapton, phosnichlor, phosphine, phoxim-methyl, pirimetaphos, polychlorodicyclopentadiene isomers, potassium arsenite, potassium thiocyanate, precocene I, precocene II, precocene III, primidophos, profluthrin, promecarb, prothiofos, pyrazophos, pyresmethrin, quassia, quinalphos-methyl, quinothion, rafoxanide, resmethrin, rotenone, kadethrin, ryania, ryanodine, sabadilla), schradan, sebufos, SI-0009, thiapronil, sodium arsenite, sodium cyanide, sodium fluoride, sodium hexafluorosilicate, sodium pentachlorophenoxide, sodium selenate, sodium thiocyanate, sulcofuron, sulcofuron-sodium, sulfuryl fluoride, sulprofos, tar oils, tazimcarb, TDE, tebupirimfos, temephos, terallethrin, tetrachloroethane, thicrofos, thiocyclam, thiocyclam hydrogen oxalate, thionazin, thiosultap, thiosultap-sodium, tralomethrin, transpermethrin, triazamate, trichlormetaphos-3, trichloronat, trimethacarb, tolprocarb, triclopyricarb, triprene, veratridine, veratrine, XMC, zetamethrin, zinc phosphide, zolaprofos, and meperfluthrin, tetramethylfluthrin, bis(tributyltin) oxide, bromoacetamide, ferric phosphate, niclosamide-olamine, tributyltin oxide, pyrimorph, trifenmorph, 1 ,2-dibromo-3-chloropropane, 1 ,3-dichloropropene, 3,4-dichlorotetrahydrothio- phene 1 ,1-dioxide, 3-(4-chlorophenyl)-5-methylrhodanine, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3- ylacetic acid, 6-isopentenylaminopurine, anisiflupurin, benclothiaz, cytokinins, DCIP, furfural, isamidofos, kinetin, Myrothecium verrucaria composition, tetrachlorothiophene, xylenols, zeatin, potassium ethylxanthate, acibenzolar, acibenzolar-S-methyl, Reynoutria sachalinensis extract, alphachlorohydrin, antu, barium carbonate, bisthiosemi, brodifacoum, bromadiolone, bromethalin, chlorophacinone, cholecalciferol, coumachlor, coumafuryl, coumatetralyl, crimidine, difenacoum, difethialone, diphacinone, ergocalciferol, flocoumafen, fluoroacetamide, flupropadine, flupropadine hydrochloride, norbormide, phosacetim, phosphorus, pindone, pyrinuron, scilliroside, sodium fluoroacetate, thallium sulfate, warfarin, 2-(2-butoxyethoxy)ethyl piperonylate, 5-(1 ,3-benzodioxol-5-yl)-3- hexylcyclohex-2-enone, farnesol with nerolidol, verbutin, MGK 264, piperonyl butoxide, piprotal, propyl isomer, S421 , sesamex, sesasmolin, sulfoxide, anthraquinone, copper naphthenate, copper oxychloride, dicyclopentadiene, thiram, zinc naphthenate, ziram, imanin, ribavirin, chloroinconazide, mercuric oxide, thiophanate-methyl, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furametpyr, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, paclobutrazole, pefurazoate, penconazole, prothioconazole, pyrifenox, prochloraz, propiconazole, pyrisoxazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole, ancymidol, fenarimol, nuarimol, bupirimate, dimethirimol, ethirimol, dodemorph, fenpropidin, fenpropimorph, spiroxamine, tridemorph, cyprodinil, mepanipyrim, pyrimethanil, fenpiclonil, fludioxonil, benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl, carbendazim, debacarb, fuberidazole, thiabendazole, chlozolinate, dichlozoline, myclozoline, procymidone, vinclozoline, boscalid, carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, penthiopyrad, thifluzamide, dodine, iminoctadine, azoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, trifloxystrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, ferbam, mancozeb, maneb, metiram, propineb, zineb, captafol, captan, fluoroimide, folpet, tolylfluanid, bordeaux mixture, copper oxide, mancopper, oxinecopper, nitrothal-isopropyl, edifenphos, iprobenphos, phosdiphen, tolclofos-methyl, anilazine, benthiavalicarb, blasticidin-S, chloroneb, chlorothalonil, cyflufenamid, cymoxanil, cyclobutrifluram, diclocymet, diclomezine, dicloran, diethofencarb, dimethomorph, flumorph, dithianon, ethaboxam, etridiazole, famoxadone, fenamidone, fenoxanil, ferimzone, fluazinam, flumetylsulforim, fluopicolide, fluoxytioconazole, flusulfamide, fluxapyroxad, fenhexamid, fosetyl-aluminium, hymexazol, iprovalicarb, cyazofamid, methasulfocarb, metrafenone, pencycuron, phthalide, polyoxins, propamocarb, pyribencarb, proquinazid, pyroquilon, pyriofenone, quinoxyfen, quintozene, tiadinil, triazoxide, tricyclazole, triforine, validamycin, valifenalate, zoxamide, mandipropamid, flubeneteram, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide, isoflucypram, isotianil, dipymetitrone, 6-ethyl-5,7-dioxo- pyrrolo[4,5][1 ,4]dithiino[1 ,2-c]isothiazole-3-carbonitrile, 2-(difluoromethyl)-N-[3-ethyl-1 ,1-dimethyl- indan-4-yl]pyridine-3-carboxamide, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile, (R)-3-(difluoromethyl)-1-methyl-N-[1 ,1 ,3-trimethylindan-4-yl]pyrazole-4-carboxamide, 4-(2-bromo-4- fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine, 4- (2- bromo- 4- fluorophenyl) - N- (2- chloro- 6- fluorophenyl) - 1 , 3- dimethyl- 1 H- pyrazol- 5- amine, fluindapyr, coumethoxystrobin (jiaxiangjunzhi), Ivbenmixianan, dichlobentiazox, mandestrobin, 3-(4,4-difluoro-3,4-dihydro-3,3- dimethylisoquinolin-1-yl)quinolone, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol, oxathiapiprolin, tert-butyl N-[6-[[[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2- pyridyl]carbamate, pyraziflumid, inpyrfluxam, trolprocarb, mefentrifluconazole, ipfentrifluconazole, 2- (difluoromethyl)-N-[(3R)-3-ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide, N'-(2,5-dimethyl-4- phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl- phenyl]-N-ethyl-N-methyl-formamidine, [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4- piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro-phenyl] methanesulfonate, but-3-ynyl N-[6- [[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, methyl N-[[5-[4- (2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamate, 3-chloro-6-methyl-5-phenyl-4- (2,4,6-trifluorophenyl)pyridazine, pyridachlometyl, 3-(difluoromethyl)-1-methyl-N-[1 ,1 ,3-trimethylindan- 4-yl]pyrazole-4-carboxamide, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4- methyl-tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1- yl)phenoxy]methyl]phenyl]tetrazol-5-one, aminopyrifen, ametoctradin, amisulbrom, penflufen, (Z,2E)-5- [1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, florylpicoxamid, fenpicoxamid, tebufloquin, ipflufenoquin, quinofumelin, isofetamid, N-[2-[2,4-dichloro-phenoxy]phenyl]- 3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide, N-[2-[2-chloro-4-
(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide, benzothiostrobin, phenamacril, 5-amino-1 ,3,4-thiadiazole-2-thiol zinc salt (2:1), fluopyram, flutianil, fluopimomide, pyrapropoyne, picarbutrazox, 2-(difluoromethyl)-N-(3-ethyl-1 ,1-dimethyl-indan-4- yl)pyridine-3-carboxamide, 2- (difluoromethyl) - N- ((3R) - 1 , 1 , 3- trimethylindan- 4- yl) pyridine- 3- carboxamide, 4-[[6-[2-(2,4-difluorophenyl)-1 ,1-difluoro-2-hydroxy-3-(1 ,2,4-triazol-1-yl)propyl]-3- pyridyl]oxy]benzonitrile, metyltetraprole, 2- (difluoromethyl) - N- ((3R) - 1 , 1 , 3- trimethylindan- 4- yl) pyridine- 3- carboxamide, a- (1 , 1- dimethylethyl) - a- [4'- (trifluoromethoxy) [1 , 1 '- biphenyl] - 4- yl] -5- pyrimidinemethanol, fluoxapiprolin, enoxastrobin, 4-[[6-[2-(2,4-difluorophenyl)-1 ,1-difluoro-2-hydroxy-3- (1 ,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile, 4-[[6-[2-(2,4-difluorophenyl)-1 , 1 -difluoro-2- hydroxy-3-(5-sulfanyl-1 ,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile, trinexapac, coumoxystrobin, zhongshengmycin, thiodiazole copper, zinc thiazole, amectotractin, iprodione, seboctylamine, N'-[5- bromo-2-methyl-6-[(1 S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5- bromo-2-methyl-6-[(1 R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5- bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro- 2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2- methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2015/155075); N'-[5-bromo-2-methyl-6-(2- propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (this compound may be prepared from the methods described in IPCOM000249876D); N-isopropyl-N’-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1- hydroxy-1 -phenyl-ethyl)phenyl]-N-methyl-formamidine, N’-[4-(1 -cyclopropyl-2,2,2-trifluoro-1 -hydroxy- ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2018/228896); N-ethyl-N’-[5-methoxy-2-methyl-4-[(2- trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine, N-ethyl-N’-[5-methoxy-2-methyl-4-[(2- trifuoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2019/110427); N-[(1 R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8- fluoro-quinoline-3-carboxamide, N-[(1 S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3- carboxamide, N-[(1 R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N- [(1 S)-1 -benzyl-3,3,3-trifluoro-1 -methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 R)-1 -benzyl- 1 ,3- dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide,
N-[(1 S)-1-benzyl-1 ,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N-[(1 R)-1- [(3-fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1 S)-1-[(3- fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1 R)-1-benzyl-1 ,3-dimethyl-butyl]- 8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3- carboxamide, N-((1 R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, N-((1S)-1- benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds may be prepared from the methods described in WO2017/153380); 1-(6,7-dimethylpyrazolo[1 ,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(6,7-dimethylpyrazolo[1 ,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3- dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazolo[1 ,5-a]pyridin-3-yl)isoquinoline, 4,4- difluoro-3,3-dimethyl-1 -(7-methylpyrazolo[1 ,5-a]pyridin-3-yl)isoquinoline, 1 -(6-chloro-7-methyl- pyrazolo[1 ,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline (these compounds may be prepared from the methods described in WO2017/025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3- dimethyl-isoquinoline, 1 -(4,5-dimethylbenzimidazol-1 -yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6- chloro-4,4-difluoro-3,3-dimethyl-1 -(4-methylbenzimidazol-1 -y I) isoq u in o li n e , 4,4-difluoro-1 -(5-fluoro-4- methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8- dihydro-6H-cyclopenta[e]benzimidazole (these compounds may be prepared from the methods described in WO2016/156085); N-methoxy-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide, 1 -methoxy-3-methyl-1 -[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]urea, 1 ,3-dimethoxy-1 -[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea,
3-ethy I- 1 -methoxy-1 -[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea, N-[[4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 4,4-dimethyl-2-[[4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 5,5-dimethyl-2-[[4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, ethyl 1 -[[4-[5-(trifluoromethyl)-
1 .2.4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-
1 .2.4-oxadiazol-3-yl]phenyl]methyl]-1 ,2,4-triazol-3-amine (these compounds may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689); 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol (this compound may be prepared from the methods described in WO 2017/029179); 2-[6-(4-bromophenoxy)-2- (trifluoromethyl)-3-pyridyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol (this compound may be prepared from the methods described in WO 2017/029179); 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy- propyl]imidazole-4-carbonitrile (this compound may be prepared from the methods described in WO 2016/156290); 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4- carbonitrile (this compound may be prepared from the methods described in WO 2016/156290); (4- phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate (this compound may be prepared from the methods described in WO 2014/006945); 2,6-Dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole- 1 ,3,5,7(2H,6H)-tetrone (this compound may be prepared from the methods described in WO 2011/138281) N-methyl-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzenecarbothioamide; N-methyl-
4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy- 2-methoxyimino-N,3-dimethyl-pent-3-enamide (this compound may be prepared from the methods described in WO 2018/153707); N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl- formamidine; N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound may be prepared from the methods described in WO 2016/202742); 2-(difluoromethyl)-N- [(3S)-3-ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (this compound may be prepared from the methods described in WO 2014/095675); (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methanone, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methanone (these compounds may be prepared from the methods described in WO 2017/220485); 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]acetamide (this compound may be prepared from the methods described in WO 2018/065414); ethyl 1-[[5-[5- (trifluoromethyl)-l ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate (this compound may be prepared from the methods described in WO 2018/158365); 2,2-difluoro-N-methyl-2-[4-[5- (trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]acetamide, N-[(E)-methoxyiminomethyl]-4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]benzamide, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-
1 .2.4-oxadiazol-3-yl]benzamide, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]benzamide (these compounds may be prepared from the methods described in WO 2018/202428), fluoxapiprolin, enoxastrobin, trinexapac, coumoxystrobin.
N-methoxy-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]propanamide, 1 -methoxy-3-methyl-1 -[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]urea, 1 ,3-dimethoxy-1 -[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea,
3-ethy I- 1 -methoxy-1 -[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea, N-[[4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 4,4-dimethyl-2-[[4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 5,5-dimethyl-2-[[4-[5-
(trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, ethyl 1 -[[4-[5-(trifluoromethyl)-
1 .2.4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-
1 .2.4-oxadiazol-3-yl]phenyl]methyl]-1 ,2,4-triazol-3-amine. The compounds in this paragraph may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689.
2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol (this compound may be prepared from the methods described in WO 2017/029179), 2-[6-(4-bromophenoxy)- 2-(trifluoromethyl)-3-pyridyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol (this compound may be prepared from the methods described in WO 2017/029179), 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy- propyl]imidazole-4-carbonitrile (this compound may be prepared from the methods described in WO 2016/156290), 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4- carbonitrile (this compound may be prepared from the methods described in WO 2016/156290).
(4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate (this compound may be prepared from the methods described in WO 2014/006945), 2,6-Dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6- c']d ipyrrole-1 ,3,5,7(2H,6H)-tetrone (this compound may be prepared from the methods described in WO 2011/138281), N-methyl-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzenecarbothioamide, N-methyl-
4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide, (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy- 2-methoxyimino-N,3-dimethyl-pent-3-enamide (this compound may be prepared from the methods described in WO 2018/153707), N'-(2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl- formamidine, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound may be prepared from the methods described in WO 2016/202742), 2-(difluoromethyl)-N- [(3S)-3-ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (this compound may be prepared from the methods described in WO 2014/095675), zhongshengmycin, thiodiazole copper, zinc thiazole, amectotractin, iprodione, cyclobutrifluram, flubeneteram, anisiflupurin.
N-[(1 R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 S)-1- benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 R)-1-benzyl-3,3,3- trifluoro-1 -methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 S)-1 -benzyl-3,3,3-trifluoro-1 -methyl- propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1 R)-1 -benzyl- 1 ,3-dimethyl-butyl]-7,8-difluoro-quinoline-3- carboxamide, N-[(1 S)-1 -benzyl- 1 ,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-fluoro-N- [(1 R)-1-[(3-fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide, 8-fluoro-N-[(1 S)-1-[(3- fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1 R)-1-benzyl-1 ,3-dimethyl-butyl]- 8-fluoro-quinoline-3-carboxamide, N-[(1 S)-1-benzyl-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3- carboxamide, N-((1 R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, N- ((1 S)-1 -benzyl-3-chloro-1 -methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds may be prepared from the methods described in WO 2017/153380).
1 -(6,7-dimethylpyrazolo[1 ,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1 -(6,7- dimethylpyrazolo[1 ,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl- 1 -(6-methylpyrazolo[1 ,5-a]pyridin-3-yl)isoquinoline, 4,4-difluoro-3,3-dimethyl-1 -(7-methylpyrazolo[1 ,5- a]pyridin-3-yl)isoquinoline, 1-(6-chloro-7-methyl-pyrazolo[1 ,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl- isoquinoline (these compounds may be prepared from the methods described in WO2017/025510); 1 - (4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-
1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4- methylbenzimidazol-1-yl)isoquinoline, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3- dimethyl-isoquinoline, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H cyclopenta[e]benzimidazole (these compounds may be prepared from the methods described in WO 2016/156085.
N'-[5-bromo-2-methyl-6-[(1 S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl- formamidine, N'-[5-bromo-2-methyl-6-[(1 R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl- formamidine,
N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2015/155075); N'-[5-bromo-2- methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (this compound may be prepared from the methods described in IPCOM000249876D); N-isopropyl-N’-[5-methoxy-2-methyl-4- (2, 2, 2-trifl u o ro- 1 -hydroxy-1 -phenyl-ethyl)phenyl]-N-methyl-formamidine, N’-[4-(1 -cyclopropyl-2,2,2- trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2018/228896); N-ethyl-N’-[5-methoxy-
2-methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine, N-ethyl-N’-[5-methoxy-2- methyl-4-[(2-trifuoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine (these compounds may be prepared from the methods described in WO2019/110427).
(5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methanone, (3- methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methanone (these compounds may be prepared from the methods described in WO 2017/220485); 2-oxo-N-propyl-2-[4-[5- (trifluoromethyl)-l ,2,4-oxadiazol-3-yl]phenyl]acetamide (this compound may be prepared from the methods described in WO 2018/065414); ethyl 1 -[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate (this compound may be prepared from the methods described in WO 2018/158365); 2,2-difluoro-N- methyl-2-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]acetamide, N-[(E)-methoxyiminomethyl]-4- [5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)- 1 ,2,4-oxadiazol-3-yl]benzamide, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]benzamide (these compounds may be prepared from the methods described in WO 2018/202428); N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide, [(1 S,2S)-1- methyl-2-(o-tolyl)propyl] (2S)-2-[(4-methoxy-3-propanoyloxy-pyridine-2-carbonyl)amino]propanoate, seboctylamine, chloroinconazide, flumetylsulforim, fluoxytioconazole.
The following mixtures of the compounds of Formula (I) with active ingredients are preferred. The abbreviation “TX” means one compound selected from the group consisting of the compounds as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below): a compound selected from the group of substances consisting of petroleum oils + TX, 1 , 1 -bis(4- chlorophenyl)-2-ethoxyethanol + TX, 2,4-dichlorophenyl benzenesulfonate + TX, 2-fluoro-N-methyl-N- 1 -naphthylacetamide + TX, 4-chlorophenyl phenyl sulfone + TX, acetoprole + TX, aldoxycarb + TX, amidithion + TX, amidothioate + TX, amiton + TX, amiton hydrogen oxalate + TX, amitraz + TX, aramite + TX, arsenous oxide + TX, azobenzene + TX, azothoate + TX, benomyl + TX, benoxafos + TX, benzyl benzoate + TX, bixafen + TX, brofenvalerate + TX, bromocyclen + TX, bromophos + TX, bromopropylate + TX, buprofezin + TX, butocarboxim + TX, butoxycarboxim + TX, butylpyridaben + TX, calcium polysulfide + TX, camphechlor + TX, carbanolate + TX, carbophenothion + TX, cymiazole + TX, chinomethionat + TX, chlorbenside + TX, chlordimeform + TX, chlordimeform hydrochloride + TX, chlorfenethol + TX, chlorfenson + TX, chlorfensulfide + TX, chlorobenzilate + TX, chloromebuform + TX, chloromethiuron + TX, chloropropylate + TX, chlorthiophos + TX, cinerin I + TX, cinerin II + TX, cinerins + TX, closantel + TX, coumaphos + TX, crotamiton + TX, crotoxyphos + TX, cufraneb + TX, cyanthoate + TX, DCPM + TX, DDT + TX, demephion + TX, demephion-O + TX, demephion-S + TX, demeton- methyl + TX, demeton-O + TX, demeton-O-methyl + TX, demeton-S + TX, demeton-S-methyl + TX, demeton-S-methylsulfon + TX, dichlofluanid + TX, dichlorvos + TX, dicliphos + TX, dienochlor + TX, dimefox + TX, dinex + TX, dinex-diclexine + TX, dinocap-4 + TX, dinocap-6 + TX, dinocton + TX, dinopenton + TX, dinosulfon + TX, dinoterbon + TX, dioxathion + TX, diphenyl sulfone + TX, disulfiram + TX, DNOC + TX, dofenapyn + TX, doramectin + TX, endothion + TX, eprinomectin + TX, ethoate-methyl + TX, etrimfos + TX, fenazaflor + TX, fenbutatin oxide + TX, fenothiocarb + TX, fenpyrad + TX, fen- pyroximate + TX, fenpyrazamine + TX, fenson + TX, fentrifanil + TX, flubenzimine + TX, flucycloxuron + TX, fluenetil + TX, fluorbenside + TX, FMC 1 137 + TX, formetanate + TX, formetanate hydrochloride + TX, formparanate + TX, gamma-HCH + TX, glyodin + TX, halfenprox + TX, hexadecyl cyclopropanecarboxylate + TX, isocarbophos + TX, jasmolin I + TX, jasmolin II + TX, jodfenphos + TX, lindane + TX, malonoben + TX, mecarbam + TX, mephosfolan + TX, mesulfen + TX, methacrifos + TX, methyl bromide + TX, metolcarb + TX, mexacarbate + TX, milbemycin oxime + TX, mipafox + TX, monocrotophos + TX, morphothion + TX, moxidectin + TX, naled + TX, 4-chloro-2-(2-chloro-2-methyl- propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one + TX, nifluridide + TX, nikkomycins + TX, nitrilacarb + TX, nitrilacarb 1 :1 zinc chloride complex + TX, omethoate + TX, oxydeprofos + TX, oxydisulfoton + TX, pp'-DDT + TX, parathion + TX, permethrin + TX, phenkapton + TX, phosalone + TX, phosfolan + TX, phosphamidon + TX, polychloroterpenes + TX, polynactins + TX, proclonol + TX, promacyl + TX, propoxur + TX, prothidathion + TX, prothoate + TX, pyrethrin I + TX, pyrethrin II + TX, pyrethrins + TX, pyridaphenthion + TX, pyrimitate + TX, quinalphos + TX, quintiofos + TX, R-1492 + TX, phosglycin + TX, rotenone + TX, schradan + TX, sebufos + TX, selamectin + TX, sophamide + TX, SSI- 121 + TX, sulfiram + TX, sulfluramid + TX, sulfotep + TX, sulfur + TX, diflovidazin + TX, tau-fluvalinate + TX, TEPP + TX, terbam + TX, tetradifon + TX, tetrasul + TX, thiafenox + TX, thiocarboxime + TX, thiofanox + TX, thiometon + TX, thioquinox + TX, thuringiensin + TX, triamiphos + TX, triarathene + TX, triazophos + TX, triazuron + TX, trifenofos + TX, trinactin + TX, vamidothion + TX, vaniliprole + TX, bethoxazin + TX, copper dioctanoate + TX, copper sulfate + TX, cybutryne + TX, dichlone + TX, dichlorophen + TX, endothal + TX, fentin + TX, hydrated lime + TX, nabam + TX, quinoclamine + TX, quinonamid + TX, simazine + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, crufomate + TX, piperazine + TX, thiophanate + TX, chloralose + TX, fenthion + TX, pyridin-4-amine + TX, strychnine + TX, 1 -hydroxy-1 H-pyridine-2-thione + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide + TX, 8- hydroxyquinoline sulfate + TX, bronopol + TX, copper hydroxide + TX, cresol + TX, dipyrithione + TX, dodicin + TX, fenaminosulf + TX, formaldehyde + TX, hydrargaphen + TX, kasugamycin + TX, kasugamycin hydrochloride hydrate + TX, nickel bis(dimethyldithiocarbamate) + TX, nitrapyrin + TX, octhilinone + TX, oxolinic acid + TX, oxytetracycline + TX, potassium hydroxyquinoline sulfate + TX, probenazole + TX, streptomycin + TX, streptomycin sesquisulfate + TX, tecloftalam + TX, thiomersal + TX, Adoxophyes orana GV + TX, Agrobacterium radiobacter + TX, Amblyseius spp. + TX, Anagrapha falcifera NPV + TX, Anagrus atomus + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, Autographa californica NPV + TX, Bacillus sphaericus Neide + TX, Beauveria brongniartii + TX, Chrysoperla carnea + TX, Cryptolaemus montrouzieri + TX, Cydia pomonella GV + TX, Dacnusa sibirica + TX, Diglyphus isaea + TX, Encarsia formosa + TX, Eretmocerus eremicus + TX, Heterorhabditis bacteriophora and H. megidis + TX, Hippodamia convergens + TX, Leptomastix dactylopii + TX, Macrolophus caliginosus + TX, Mamestra brassicae NPV + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopliae + TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, Orius spp. + TX, Paecilomyces fumosoroseus + TX, Phytoseiulus persimilis + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp. + TX, Trichogramma spp. + TX, Typhlodromus occidentalis + TX , Verticillium lecanii + TX, apholate + TX, bisazir + TX, busulfan + TX, dimatif + TX, hemel + TX, hempa + TX, metepa + TX, methiotepa + TX, methyl apholate + TX, morzid + TX, penfluron + TX, tepa + TX, thiohempa + TX, thiotepa + TX, tretamine + TX, uredepa + TX, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol + TX, (E)-tridec-4-en-1-yl acetate + TX, (E)-6- methylhept-2-en-4-ol + TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate + TX, (Z)-dodec-7-en-1-yl acetate + TX, (Z)-hexadec-11-enal + TX, (Z)-hexadec-l 1-en-1-yl acetate + TX, (Z)-hexadec-13-en-11-yn-1-yl acetate + TX, (Z)-icos-13-en-10-one + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-tetradec-9-en-1-ol + TX, (Z)- tetradec-9-en-1-yl acetate + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate + TX, (9Z,11 E)-tetradeca-9,11- dien-1-yl acetate + TX, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate + TX, 14-methyloctadec-1-ene + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one + TX, alpha-multistriatin + TX, brevicomin + TX, codlelure + TX, codlemone + TX, cuelure + TX, disparlure + TX, dodec-8-en-1-yl acetate + TX, dodec- 9-en-1-yl acetate + TX, dodeca-8 + TX, 10-dien-1-yl acetate + TX, dominicalure + TX, ethyl 4- methyloctanoate + TX, eugenol + TX, frontalin + TX, grandlure + TX, grandlure I + TX, grandlure II + TX, grandlure III + TX, grandlure IV + TX, hexalure + TX, ipsdienol + TX, ipsenol + TX, japonilure + TX, lineatin + TX, litlure + TX, looplure + TX, medlure + TX, megatomoic acid + TX, methyl eugenol + TX, muscalure + TX, octadeca-2,13-dien-1-yl acetate + TX, octadeca-3,13-dien-1-yl acetate + TX, orfralure + TX, oryctalure + TX, ostramone + TX, siglure + TX, sordidin + TX, sulcatol + TX, tetradec-11 -en-1 -yl acetate + TX, trimedlure + TX, trimedlure A + TX, trimedlure Bi + TX, trimedlure B2 + TX, trimedlure C + TX, trunc-call + TX, 2-(octylthio)ethanol + TX, butopyronoxyl + TX, butoxy(polypropylene glycol) + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, diethyltoluamide + TX, dimethyl carbate + TX, dimethyl phthalate + TX, ethyl hexanediol + TX, hexamide + TX, methoquin-butyl + TX, methylneodecanamide + TX, oxamate + TX, picaridin + TX, 1-dichloro-1 -nitroethane + TX, 1 ,1 -dichloro- 2,2-bis(4-ethylphenyl)ethane + TX, 1 ,2-dichloropropane with 1 ,3-dichloropropene + TX, 1-bromo-2- chloroethane + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate + TX, 2,2-dichlorovinyl 2- ethylsulfinylethyl methyl phosphate + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate + TX, 2-(2- butoxyethoxy)ethyl thiocyanate + TX, 2-(4,5-dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate + TX, 2-(4-chloro-3,5-xylyloxy)ethanol + TX, 2-chlorovinyl diethyl phosphate + TX, 2-imidazolidone + TX, 2- isovalerylindan-1 ,3-dione + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate + TX, 2- thiocyanatoethyl laurate + TX, 3-bromo-1 -chloroprop-1 -ene + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate + TX, 5,5-dimethyl-3- oxocyclohex-1-enyl dimethylcarbamate + TX, acethion + TX, acrylonitrile + TX, aldrin + TX, allosamidin + TX, allyxycarb + TX, alpha-ecdysone + TX, aluminium phosphide + TX, aminocarb + TX, anabasine + TX, athidathion + TX, azamethiphos + TX, Bacillus thuringiensis delta endotoxins + TX, barium hexafluorosilicate + TX, barium polysulfide + TX, barthrin + TX, Bayer 22/190 + TX, Bayer 22408 + TX, beta-cyfluthrin + TX, beta-cypermethrin + TX, bioethanomethrin + TX, biopermethrin + TX, bis(2- chloroethyl) ether + TX, borax + TX, bromfenvinfos + TX, bromo-DDT + TX, bufencarb + TX, butacarb + TX, butathiofos + TX, butonate + TX, calcium arsenate + TX, calcium cyanide + TX, carbon disulfide + TX, carbon tetrachloride + TX, cartap hydrochloride + TX, cevadine + TX, chlorbicyclen + TX, chlordane + TX, chlordecone + TX, chloroform + TX, chloropicrin + TX, chlorphoxim + TX, chlorprazophos + TX, cis-resmethrin + TX, cismethrin + TX, clocythrin + TX, copper acetoarsenite + TX, copper arsenate + TX, copper oleate + TX, coumithoate + TX, cryolite + TX, CS 708 + TX, cyanofenphos + TX, cyanophos + TX, cyclethrin + TX, cythioate + TX, d-tetramethrin + TX, DAEP + TX, dazomet + TX, decarbofuran + TX, diamidafos + TX, dicapthon + TX, dichlofenthion + TX, dicresyl + TX, dicyclanil + TX, dieldrin + TX, diethyl 5-methylpyrazol-3-yl phosphate + TX, dilor + TX, dimefluthrin + TX, dimetan + TX, dimethrin + TX, dimethylvinphos + TX, dimetilan + TX, dinoprop + TX, dinosam + TX, dinoseb + TX, diofenolan + TX, dioxabenzofos + TX, dithicrofos + TX, DSP + TX, ecdysterone + TX, El 1642 + TX, EMPC + TX, EPBP + TX, etaphos + TX, ethiofencarb + TX, ethyl formate + TX, ethylene dibromide + TX, ethylene dichloride + TX, ethylene oxide + TX, EXD + TX, fenchlorphos + TX, fenethacarb + TX, fenitrothion + TX, fenoxacrim + TX, fenpirithrin + TX, fensulfothion + TX, fenthion- ethyl + TX, flucofuron + TX, fosmethilan + TX, fospirate + TX, fosthietan + TX, furathiocarb + TX, furethrin + TX, guazatine + TX, guazatine acetates + TX, sodium tetrathiocarbonate + TX, halfenprox + TX, HCH + TX, HEOD + TX, heptachlor + TX, heterophos + TX, HHDN + TX, hydrogen cyanide + TX, hyquincarb + TX, IPSP + TX, isazofos + TX, isobenzan + TX, isodrin + TX, isofenphos + TX, isolane + TX, isoprothiolane + TX, isoxathion + TX, juvenile hormone I + TX, juvenile hormone II + TX, juvenile hormone III + TX, kelevan + TX, kinoprene + TX, lead arsenate + TX, leptophos + TX, lirimfos + TX, lythidathion + TX, m-cumenyl methylcarbamate + TX, magnesium phosphide + TX, mazidox + TX, mecarphon + TX, menazon + TX, mercurous chloride + TX, mesulfenfos + TX, metam + TX, metam- potassium + TX, metam-sodium + TX, methanesulfonyl fluoride + TX, methocrotophos + TX, methoprene + TX, methothrin + TX, methoxychlor + TX, methyl isothiocyanate + TX, methylchloroform + TX, methylene chloride + TX, metoxadiazone + TX, mirex + TX, naftalofos + TX, naphthalene + TX, NC-170 + TX, nicotine + TX, nicotine sulfate + TX, nithiazine + TX, nornicotine + TX, 0-5-dichloro-4- iodophenyl O-ethyl ethylphosphonothioate + TX, O,O-diethyl 0-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate + TX, O,O-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate + TX, 0,0,0',0'-tetrapropyl dithiopyrophosphate + TX, oleic acid + TX, para-dichlorobenzene + TX, parathion-methyl + TX, pentachlorophenol + TX, pentachlorophenyl laurate + TX, PH 60-38 + TX, phenkapton + TX, phosnichlor + TX, phosphine + TX, phoxim-methyl + TX, pirimetaphos + TX, polychlorodicyclopentadiene isomers + TX, potassium arsenite + TX, potassium thiocyanate + TX, precocene I + TX, precocene II + TX, precocene III + TX, primidophos + TX, profluthrin + TX, promecarb + TX, prothiofos + TX, pyrazophos + TX, pyresmethrin + TX, quassia + TX, quinalphos-methyl + TX, quinothion + TX, rafoxanide + TX, resmethrin + TX, rotenone + TX, kadethrin + TX, ryania + TX, ryanodine + TX, sabadilla) + TX, schradan + TX, sebufos + TX, SI-0009 + TX, thiapronil + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoride + TX, sodium hexafluorosilicate + TX, sodium pentachlorophenoxide + TX, sodium selenate + TX, sodium thiocyanate + TX, sulcofuron + TX, sulcofuron-sodium + TX, sulfuryl fluoride + TX, sulprofos + TX, tar oils + TX, tazimcarb + TX, TDE + TX, tebupirimfos + TX, temephos + TX, terallethrin + TX, tetrachloroethane + TX, thicrofos + TX, thiocyclam + TX, thiocyclam hydrogen oxalate + TX, thionazin + TX, thiosultap + TX, thiosultap-sodium + TX, tralomethrin + TX, transpermethrin + TX, triazamate + TX, trichlormetaphos-3 + TX, trichloronat + TX, trimethacarb + TX, tolprocarb + TX, triclopyricarb + TX, triprene + TX, veratridine + TX, veratrine + TX, XMC + TX, zetamethrin + TX, zinc phosphide + TX, zolaprofos + TX, and meperfluthrin + TX, tetramethylfluthrin + TX, bis(tributyltin) oxide + TX, bromoacetamide + TX, ferric phosphate + TX, niclosamide-olamine + TX, tributyltin oxide + TX, pyrimorph + TX, trifenmorph + TX, 1 ,2-dibromo-3- chloropropane + TX, 1 ,3-dichloropropene + TX, 3,4-dichlorotetrahydrothiophene 1 ,1 -dioxide + TX, 3-(4- chlorophenyl)-5-methylrhodanine + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3-ylacetic acid + TX, 6- isopentenylaminopurine + TX, 2-fluoro-N-(3-methoxyphenyl)-9H-purin-6-amine + TX, benclothiaz + TX, cytokinins + TX, DCIP + TX, furfural + TX, isamidofos + TX, kinetin + TX, Myrothecium verrucaria composition + TX, tetrachlorothiophene + TX, xylenols + TX, zeatin + TX, potassium ethylxanthate + TX .acibenzolar + TX, acibenzolar-S-methyl + TX, Reynoutria sachalinensis extract + TX, alphachlorohydrin + TX, antu + TX, barium carbonate + TX, bisthiosemi + TX, brodifacoum + TX, bromadiolone + TX, bromethalin + TX, chlorophacinone + TX, cholecalciferol + TX, coumachlor + TX, coumafuryl + TX, coumatetralyl + TX, crimidine + TX, difenacoum + TX, difethialone + TX, diphacinone + TX, ergocalciferol + TX, flocoumafen + TX, fluoroacetamide + TX, flupropadine + TX, flupropadine hydrochloride + TX, norbormide + TX, phosacetim + TX, phosphorus + TX, pindone + TX, pyrinuron + TX, scilliroside + TX, sodium fluoroacetate + TX, thallium sulfate + TX, warfarin + TX, 2-(2- butoxyethoxy)ethyl piperonylate + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone + TX, farnesol with nerolidol + TX, verbutin + TX, MGK 264 + TX, piperonyl butoxide + TX, piprotal + TX, propyl isomer + TX, S421 + TX, sesamex + TX, sesasmolin + TX, sulfoxide + TX, anthraquinone + TX, copper naphthenate + TX, copper oxychloride + TX, dicyclopentadiene + TX, thiram + TX, zinc naphthenate + TX, ziram + TX, imanin + TX, ribavirin + TX, mercuric oxide + TX, thiophanate-methyl + TX, azaconazole + TX, bitertanol + TX, bromuconazole + TX, cyproconazole + TX, difenoconazole + TX, diniconazole + TX, epoxiconazole + TX, fenbuconazole + TX, fluquinconazole + TX, flusilazole + TX, flutriafol + TX, furametpyr + TX, hexaconazole + TX, imazalil + TX, imibenconazole + TX, ipconazole + TX, metconazole + TX, myclobutanil + TX, paclobutrazole + TX, pefurazoate + TX, penconazole + TX, prothioconazole + TX, pyrifenox + TX, prochloraz + TX, propiconazole + TX, pyrisoxazole + TX, - simeconazole + TX, tebuconazole + TX, tetraconazole + TX, triadimefon + TX, triadimenol + TX, triflumizole + TX, triticonazole + TX, ancymidol + TX, fenarimol + TX, nuarimol + TX, bupirimate + TX, dimethirimol + TX, ethirimol + TX, dodemorph + TX, fenpropidin + TX, fenpropimorph + TX, spiroxamine + TX, tridemorph + TX, cyprodinil + TX, mepanipyrim + TX, pyrimethanil + TX, fenpiclonil + TX, fludioxonil + TX, benalaxyl + TX, furalaxyl + TX, metalaxyl -+ TX, Rmetalaxyl + TX, ofurace + TX, oxadixyl + TX, carbendazim + TX, debacarb + TX, fuberidazole + TX, thiabendazole + TX, chlozolinate + TX, dichlozoline + TX, myclozoline + TX, procymidone + TX, vinclozoline + TX, boscalid + TX, carboxin + TX, fenfuram + TX, flutolanil + TX, mepronil + TX, oxycarboxin + TX, penthiopyrad + TX, thifluzamide + TX, dodine + TX, iminoctadine + TX, azoxystrobin + TX, dimoxystrobin + TX, enestroburin + TX, fenaminstrobin + TX, flufenoxystrobin + TX, fluoxastrobin + TX, kresoxim-methyl + TX, metominostrobin + TX, trifloxystrobin + TX, orysastrobin + TX, picoxystrobin + TX, pyraclostrobin + TX, pyrametostrobin + TX, pyraoxystrobin + TX, ferbam + TX, mancozeb + TX, maneb + TX, metiram + TX, propineb + TX, zineb + TX, captafol + TX, captan + TX, fluoroimide + TX, folpet + TX, tolylfluanid + TX, bordeaux mixture + TX, copper oxide + TX, mancopper + TX, oxine-copper + TX, nitrothal- isopropyl + TX, edifenphos + TX, iprobenphos + TX, phosdiphen + TX, tolclofos-methyl + TX, anilazine + TX, benthiavalicarb + TX, blasticidin-S + TX, chloroneb + TX, chlorothalonil + TX, cyflufenamid + TX, cymoxanil + TX, cyclobutrifluram + TX, diclocymet + TX, diclomezine + TX, dicloran + TX, diethofencarb + TX, dimethomorph + TX, flumorph + TX, dithianon + TX, ethaboxam + TX, etridiazole + TX, famoxadone + TX, fenamidone + TX, fenoxanil + TX, ferimzone + TX, fluazinam + TX, fluopicolide + TX, flusulfamide + TX, fluxapyroxad + TX, fenhexamid + TX, fosetyl-aluminium + TX, hymexazol + TX, iprovalicarb + TX, cyazofamid + TX, methasulfocarb + TX, metrafenone + TX, pencycuron + TX, phthalide + TX, polyoxins + TX, propamocarb + TX, pyribencarb + TX, proquinazid + TX, pyroquilon + TX, pyriofenone + TX, quinoxyfen + TX, quintozene + TX, tiadinil + TX, triazoxide + TX, tricyclazole + TX, triforine + TX, validamycin + TX, valifenalate + TX, zoxamide + TX, mandipropamid + TX, flubeneteram + TX, isopyrazam + TX, sedaxane + TX, benzovindiflupyr + TX, pydiflumetofen + TX, 3- difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide + TX, isoflucypram + TX, isotianil + TX, dipymetitrone + TX, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1 ,4]dithiino[1 ,2- c]isothiazole-3-carbonitrile + TX, 2-(difluoromethyl)-N-[3-ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3- carboxamide + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile + TX, (R)-3- (difluoromethyl)-1-methyl-N-[1 ,1 ,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 4-(2-bromo-4- fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine + TX, 4- (2- bromo- 4- fluorophenyl) - N- (2- chloro- 6- fluorophenyl) - 1 , 3- dimethyl- 1 H- pyrazol- 5- amine + TX, fluindapyr + TX, coumethoxystrobin (jiaxiangjunzhi) + TX, Ivbenmixianan + TX, dichlobentiazox + TX, mandestrobin + TX, 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone + TX, 2-[2-fluoro- 6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol + TX, oxathiapiprolin + TX, tert-butyl N-[6-[[[(1- methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, pyraziflumid + TX, inpyrfluxam + TX, trolprocarb + TX, mefentrifluconazole + TX, ipfentrifluconazole+ TX, 2- (difluoromethyl)-N-[(3R)-3-ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, N'-(2,5-dimethyl- 4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5- dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + TX, [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1- yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro-phenyl] methanesulfonate + TX, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, methyl N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamate + TX, 3- chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + TX, pyridachlometyl + TX, 3- (difluoromethyl)-1-methyl-N-[1 ,1 ,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 1-[2-[[1-(4- chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one + TX, 1 -methyl-4-[3- methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1 -yl)phenoxy]methyl]phenyl]tetrazol-5-one + TX, aminopyrifen + TX, ametoctradin + TX, amisulbrom + TX, penflufen + TX, (Z,2E)-5-[1-(4- chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX, florylpicoxamid + TX, fenpicoxamid + TX, tebufloquin + TX, ipflufenoquin + TX, quinofumelin + TX, isofetamid + TX, N- [2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1 -methyl-pyrazole-4-carboxamide + TX, N-[2-[2- chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide + TX, benzothiostrobin + TX, phenamacril + TX, 5-amino-1 ,3,4-thiadiazole-2-thiol zinc salt (2:1) + TX, fluopyram + TX, flutianil + TX, fluopimomide + TX, pyrapropoyne + TX, picarbutrazox + TX, 2- (difluoromethyl)-N-(3-ethyl-1 ,1-dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2- (difluoromethyl) - N- ((3R) - 1 , 1 , 3- trimethylindan- 4- yl) pyridine- 3- carboxamide + TX, 4-[[6-[2-(2,4-difluorophenyl)-1 ,1- difluoro-2-hydroxy-3-(1 ,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, metyltetraprole + TX, 2- (difluoromethyl) - N- ((3R) - 1 , 1 , 3- trimethylindan- 4- yl) pyridine- 3- carboxamide + TX, a- (1 , 1- dimethylethyl) - a- [4'- (trifluoro methoxy) [1 , 1'- biphenyl] - 4- yl] -5- pyrimidinemethanol + TX, fluoxapiprolin + TX, enoxastrobin + TX, 4-[[6-[2-(2,4-difluorophenyl)-1 ,1-difluoro-2-hydroxy-3-(1 ,2,4- triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1 ,1-difluoro-2-hydroxy- 3-(5-sulfanyl-1 ,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy] benzonitrile + TX, 4-[[6-[2-(2,4-difluorophenyl)-1 ,1- difluoro-2-hydroxy-3-(5-thioxo-4H-1 ,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, trinexapac + TX, coumoxystrobin + TX, zhongshengmycin + TX, thiodiazole copper + TX, zinc thiazole + TX, amectotractin + TX, iprodione + TX, N-octyl-N'-[2-(octylamino)ethyl]ethane-1 ,2-diamine + TX; N'-[5- bromo-2-methyl-6-[(1 S)-1 -methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'- [5-bromo-2-methyl-6-[(1 R)-1 -methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5-bromo-2-methyl-6-(1 -methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'- [5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX, N'-[5- bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds may be prepared from the methods described in WO2015/155075); N'-[5-bromo-2- methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine + TX (this compound may be prepared from the methods described in IPCOM000249876D); N-isopropyl-N’-[5-methoxy-2-methyl-4- (2, 2, 2-trifluoro-1 -hydroxy-1 -phenyl-ethyl)phenyl]-N-methyl-formamidine+ TX, N’-[4-(1-cyclopropyl-
2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine + TX (these compounds may be prepared from the methods described in WO2018/228896); N-ethyl-N’-[5- methoxy-2-methyl-4-[2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine + TX, N-ethyl-N’-[5- methoxy-2-methyl-4-[2-trifuoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine + TX (these compounds may be prepared from the methods described in WO2019/1 10427); N-[(1 R)-1-benzyl-3- chloro-1 -methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1 S)-1 -benzyl-3-chloro-1 - methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1 R)-1-benzyl-3,3,3-trifluoro-1-methyl- propyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1 S)-1 -benzyl-3,3,3-trifluoro-1 -methyl-propyl]-8- fluoro-quinoline-3-carboxamide + TX, N-[(1 R)-1-benzyl-1 ,3-dimethyl-butyl]-7,8-difluoro-quinoline-3- carboxamide + TX, N-[(1 S)-1-benzyl-1 ,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide + TX, 8- fluoro-N-[(1 R)-1-[(3-fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide + TX, 8-fluoro-N- [(1 S)-1 -[(3-fluorophenyl)methyl]-1 ,3-dimethyl-butyl]quinoline-3-carboxamide + TX, N-[(1 R)-1 -benzyl-
1 .3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1 S)-1 -benzyl- 1 ,3-dimethyl-butyl]-8- fluoro-quinoline-3-carboxamide + TX, N-((1 R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro- quinoline-3-carboxamide + TX, N-((1 S)-1 -benzyl-3-chloro-1 -methyl-but-3-enyl)-8-fluoro-quinoline-3- carboxamide + TX (these compounds may be prepared from the methods described in WO2017/153380);
1-(6,7-dimethylpyrazolo[1 ,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1- (6,7-dimethylpyrazolo[1 ,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline + TX, 4,4-difluoro-3,3- dimethyl-1-(6-methylpyrazolo[1 ,5-a]pyridin-3-yl)isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(7- methylpyrazolo[1 ,5-a]pyridin-3-yl)isoquinoline + TX, 1-(6-chloro-7-methyl-pyrazolo[1 ,5-a]pyridin-3-yl)-
4.4-difluoro-3,3-dimethyl-isoquinoline + TX (these compounds may be prepared from the methods described in WO2017/025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl- isoquinoline + TX, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline + TX, 6- chloro-4,4-difluoro-3,3-dimethyl-1 -(4-methylbenzimidazol-1 -y I) isoq u ino li n e + TX, 4,4-difluoro-1 -(5- fluoro-4-methyl-benzimidazol-1 -yl)-3,3-dimethyl-isoquinoline + TX, 3-(4,4-difluoro-3,3-dimethyl-1 - isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole + TX (these compounds may be prepared from the methods described in WO2016/156085); N-methoxy-N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]cyclopropanecarboxamide + TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]phenyl]methyl]propanamide + TX, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]phenyl]methyl]propanamide + TX, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]phenyl]methyl]urea + TX, 1 ,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]urea + TX, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3- yl]phenyl]methyl]urea + TX, N-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + TX, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one + TX, ethyl 1-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate + TX, N,N-dimethyl- 1-[[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]-1 ,2,4-triazol-3-amine + TX. The compounds in this paragraph may be prepared from the methods described in WO 2017/055473, WO 2017/055469, WO 2017/093348 and WO 2017/118689; 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3- pyridyl]-1-(1 ,2,4-triazol-1-yl)propan-2-ol + TX (this compound may be prepared from the methods described in WO 2017/029179); 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1 ,2,4-triazol-1- yl)propan-2-ol + TX (this compound may be prepared from the methods described in WO 2017/029179); 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + TX (this compound may be prepared from the methods described in WO 2016/156290); 3-[2-(1- chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile + TX (this compound may be prepared from the methods described in WO 2016/156290); (4- phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate + TX (this compound may be prepared from the methods described in WO 2014/006945); 2,6-Dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6- c']d ipyrrole-1 ,3,5,7(2H,6H)-tetrone + TX (this compound may be prepared from the methods described in WO 2011/138281); N-methyl-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzenecarbothioamide + TX; N-methyl-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide + TX; (Z,2E)-5-[1-(2,4- dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide + TX (this compound may be prepared from the methods described in WO 2018/153707); N'-(2-chloro-5-methyl-4-phenoxy- phenyl)-N-ethyl-N-methyl-formamidine + TX; N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N- ethyl-N-methyl-formamidine + TX (this compound may be prepared from the methods described in WO 2016/202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1 ,1-dimethyl-indan-4-yl]pyridine-3-carboxamide + TX (this compound may be prepared from the methods described in WO 2014/095675); (5-methyl-2- pyridyl)-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methanone + TX, (3-methylisoxazol-5-yl)-[4- [5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methanone + TX (these compounds may be prepared from the methods described in WO 2017/220485); 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1 ,2,4- oxadiazol-3-yl]phenyl]acetamide + TX (this compound may be prepared from the methods described in WO 2018/065414); ethyl 1-[[5-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4- carboxylate + TX (this compound may be prepared from the methods described in WO 2018/158365) ; 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]acetamide + TX, N-[(E)- methoxyiminomethyl]-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide + TX, N-[(Z)- methoxyiminomethyl]-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide + TX, N-[N-methoxy-C- methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzamide + TX (these compounds may be prepared from the methods described in WO 2018/202428), chloroinconazide + TX, seboctylamine + TX, chloroinconazide + TX, flumetylsulforim + TX, fluoxytioconazole + TX. The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995-2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.
Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. “CAS Reg. No” means the Chemical Abstracts Registry Number.
The active ingredient mixture of the compounds of formula (I) selected from one compound as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below) is preferably in a mixing ratio of from 100:1 to 1 :6000, especially from 50:1 to 1 :50, more especially in a ratio of from 20:1 to 1 :20, even more especially from 10:1 to 1 :10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5:1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 :150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are by weight.
The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.
The mixtures comprising a compound as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below), and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying a compound as represented in Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 (below), or a compound listed in Table T1 (below) and the active ingredient(s) as described above, is not essential for working the present invention. The compounds of the invention may also be used in combination with anthelmintic agents. Such anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP- 444964 and EP-594291 . Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO- 9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.
The compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE-19520936.
The compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/1 1945, WO 93/19053, WO 93/25543, EP 0 626 375, EP 0 382 173, WO 94/19334, EP 0 382 173, and EP 0 503 538.
The compounds of the invention may be used in combination with other ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like; neonicotinoids such as imidacloprid and the like.
The compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein.
Other examples of such biologically active compounds that the compounds of the invention may be used in combination with include but are not restricted to the following:
Organophosphates: acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, methacriphos, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, paraoxon, parathion, parathion-methyl, phenthoate, phosalone, phosfolan, phosphocarb, phosmet, phosphamidon, phorate, phoxim, pirimiphos, pirimiphos-methyl, profenofos, propaphos, proetamphos, prothiofos, pyraclofos, pyridapenthion, quinalphos, sulprophos, temephos, terbufos, tebupirimfos, tetrachlorvinphos, thimeton, triazophos, trichlorfon, vamidothion.
Carbamates: alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801 , isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
Pyrethroids: acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E)-(1 R)-cis-2,2-dimethyl- 3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta-cyfluthrin, cyfluthrin, a- cypermethrin, beta-cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (D isomer), imiprothrin, cyhalothrin, lambda-cyhalothrin, permethrin, phenothrin, prallethrin, pyrethrins (natural products), resmethrin, tetramethrin, transfluthrin, theta-cypermethrin, silafluofen, t-fluvalinate, tefluthrin, tralomethrin, Zeta-cypermethrin.
Arthropod growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.
Other antiparasitics: acequinocyl, amitraz, AKD-1022, ANS-118, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydramethylnon, I KI-220 , kanemite, NC-196, neem guard, nidinorterfuran, nitenpyram, SD-35651 , WL-108477, pirydaryl, propargite, protrifenbute, pymethrozine, pyridaben, pyrimidifen, NC-1111 , R-195.RH-0345, RH-2485, RYI-210, S-1283, S-1833, SI-8601 , silafluofen, silomadine, spinosad, tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosyn, trinactin, verbutin, vertalec, YI-5301 .
Biological agents: Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.
Bactericides: chlortetracycline, oxytetracycline, streptomycin.
Other biological agents: enrofloxacin, febantel, penethamate, moloxicam, cefalexin, kanamycin, pimobendan, clenbuterol, omeprazole, tiamulin, benazepril, pyriprole, cefquinome, florfen icol, buserelin, cefovecin, tulathromycin, ceftiour, carprofen, metaflumizone, praziquarantel, triclabendazole.
The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.
The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds (I) forthe preparation ofthese compositions are also a subject ofthe invention.
Another aspect of the invention is related to the use of a compound of Formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, or of a fungicidal or insecticidal mixture comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.
A further aspect of the invention is related to a method of controlling or preventing an infestation of plants, e.g., useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g., harvested food crops, or of non-living materials by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of Formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.
Controlling or preventing means reducing infestation by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.
A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of Formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compounds of Formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid Formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of Formula (I) may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
A formulation, e.g. a composition containing the compound of Formula (I), and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of Formula (I), may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).
Advantageous rates of application are normally from 5g to 2kg of active ingredient (a.i.) per hectare (ha), preferably from 10g to 1 kg a.i./ha, most preferably from 20g to 600g a.i./ha. When used as seed drenching agent, convenient dosages are from 10mg to 1g of active substance per kg of seeds.
When the combinations of the present invention are used for treating seed, rates of 0.001 to 50 g of a compound of Formula (I) per kg of seed, preferably from 0.01 to 10g per kg of seed are generally sufficient. Suitably, a composition comprising a compound of Formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.
The compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EG), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.
Such compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects). Also conventional slow release formulations may be employed where long lasting efficacy is intended. Particularly Formulations to be applied in spraying forms, such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g. the condensation product of formaldehyde with naphthalene sulphonate, an alkylarylsulphonate, a lignin sulphonate, a fatty alkyl sulphate, and ethoxylated alkylphenol and an ethoxylated fatty alcohol.
A seed dressing formulation is applied in a manner known per se to the seeds employing the combination ofthe invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds. Such seed dressing formulations are known in the art. Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules.
In general, the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of Formula (I) optionally together with other active agents, particularly microbiocides or conservatives or the like. Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent. Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations.
Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations. The compounds according to the following Tables A1 to A12 and Tables B1 to B12 and Tables C1 to C12 and Tables D1 to D12 below can be prepared according to the methods described above. The examples which follow are intended to illustrate the invention and show preferred compounds of formula (I).
Table G: This table discloses 100 substituent definitions (G) of compounds of the formula (I), according to the invention, wherein G (comprising -N(H)-, R2, R3, R4, R5 and R6) according to compounds of Formula (I) of the invention is
Figure imgf000048_0001
and wherein the G substituents are as defined below in Table G:
Table G:
Figure imgf000048_0002
Figure imgf000049_0001
Figure imgf000050_0001
Figure imgf000051_0003
The following tables Tables A1 show specific compounds of formula (IA) wherein G substituents are as defined above in Table G. In formula (IA), Q corresponds to R1 in formula (I).
Figure imgf000051_0001
Table A1 : This table provides 100 compounds A1-1 to A1-100 of formula (IA) wherein Q is 3-methyl- phenyl, and G is as defined above in Table G.
For example, compound A1-52 has the following structure:
Figure imgf000051_0002
Compound A1-52
Table A2: This table provides 100 compounds A2-1 to A2-100 of formula (IA) wherein Q is 3-phenyl and G is as defined above in Table G.
Table A3: This table provides 100 compounds A3-1 to A3-100 of formula (IA) wherein Q is 3- chlorophenyl and G is as defined above in Table g.
Table A4: This table provides 100 compounds A4-1 to A4-100 of formula (IA) wherein Q is 3- cyclopropylphenyl and G is as defined above in Table G.
Table A5: This table provides 100 compounds A5-1 to A5-100 of formula (IA) wherein Q is 3- ethynylphenyl and G is as defined above in Table g.
Table A6: This table provides 100 compounds A6-1 to A6-100 of formula (IA) wherein Q is 3- trifluoromethylphenyl and G is as defined above in Table G.
Table A7: This table provides 100 compounds A7-1 to A7-100 of formula (IA) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
Table A8: This table provides 100 compounds A8-1 to A8-100 of formula (IA) wherein Q is 3-pyridyl and G is as defined above in Table G.
Table A9: This table provides 100 compounds A9-1 to A9-100 of formula (IA) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
Table A10: This table provides 100 compounds A10-1 to A10-100 of formula (IA) wherein Q is 5-fluoro-
3-pyridyl and G is as defined above in Table G. Table A11 : This table provides 100 compounds A11 -1 to A11 -100 of formula (IA) wherein Q is 5-methyl- 3-pyridyl and G is as defined above in Table G.
Table A12: This table provides 100 compounds A12-1 to A12-100 of formula (IA) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G.
The following Tables B1 to B12 show specific compounds of formula (IB) whose G substituents are as defined above in Table G. In formula (IB), Q corresponds to R1 in formula (I).
Figure imgf000052_0001
Table B1 : This table provides 100 compounds B1-1 to B1-100 of formula (IB) wherein Q is phenyl and
G is as defined above in Table G. For example, compound B1-90 has the following structure:
Figure imgf000052_0002
Compound B1-90
Table B2: This table provides 100 compounds B2-1 to B2-100 of formula (IB) wherein Q is 3- methylphenyl and G is as defined above in Table G.
Table B3: This table provides 100 compounds B3-1 to B3-100 of formula (IB) wherein Q is 3- chlorophenyl and G is as defined above in Table G.
Table B4: This table provides 100 compounds B4-1 to B4-100 of formula (IB) wherein Q is 3- cyclopropyl-phenyl and G is as defined above in Table G.
Table B5: This table provides 100 compounds B5-1 to B5-100 of formula (IB) wherein Q is 3- ethynylphenyl and G is as defined above in Table G.
Table B6: This table provides 100 compounds B6-1 to B6-100 of formula (IB) wherein Q is 3- trifluoromethylphenyl and G is as defined above in Table G.
Table B7: This table provides 100 compounds B7-1 to B7-100 of formula (IB) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
Table B8: This table provides 100 compounds B8-1 to B8-100 of formula (IB) wherein Q is 3-pyridyl and G is as defined above in Table G.
Table B9: This table provides 100 compounds B9-1 to B9-100 of formula (IB) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
Table B10: This table provides 100 compounds B10-1 to B10-100 of formula (IB) wherein Q is 5-fluoro- 3-pyridyl and G is as defined above in Table G.
Table B11 : This table provides 100 compounds B11 -1 to B11 -100 of formula (IB) wherein Q is 5-methyl-
3-pyridyl and G is as defined above in Table G. Table B12: This table provides 100 compounds B12-1 to B12-100 of formula (IB) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G. The following Tables C1 to C12 show specific compounds of formula (IC) whose G substituents are as defined above in Table G. In formula (IC), Q corresponds to R1 in formula (I).
Figure imgf000053_0001
Table C1: This table provides 100 compounds C1-1 to C1-100 of formula (IC) wherein Q is 3- trifluoromethyl-phenyl and G is as defined above in Table G. For example, compound C1-67 has the following structure:
Figure imgf000053_0002
Compound C1-67 Table C2: This table provides 100 compounds C2-1 to C2-100 of formula (IC) wherein Q is 3-phenyl and G is as defined above in Table G. Table C3: This table provides 100 compounds C3-1 to C3-100 of formula (IC) wherein Q is 3- methylphenyl and G is as defined above in Table G. Table C4: This table provides 100 compounds C4-1 to C4-100 of formula (IC) wherein Q is 3- chlorophenyl and G is as defined above in Table G. Table C5: This table provides 100 compounds C5-1 to C5-100 of formula (IC) wherein Q is 3- cyclopropylphenyl and G is as defined above in Table G. Table C6: This table provides 100 compounds C6-1 to C6-100 of formula (IC) wherein Q is 3- ethynylphenyl and G is as defined above in Table G. Table C7: This table provides 100 compounds C7-1 to C7-100 of formula (IC) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G. Table C8: This table provides 100 compounds C8-1 to C8-100 of formula (IC) wherein Q is 3-pyridyl and G is as defined above in Table G. Table C9: This table provides 100 compounds C9-1 to C9-100 of formula (IC) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G. Table C10: This table provides 100 compounds C10-1 to C10-100 of formula (IC) wherein Q is 5-fluoro- 3-pyridyl and G is as defined above in Table G. Table C11: This table provides 100 compounds C11-1 to C11-100 of formula (IC) wherein Q is 5-methyl- 3-pyridyl and G is as defined above in Table G. Table C12: This table provides 100 compounds C12-1 to C12-100 of formula (IC) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G.
The following Tables D1 to D12 show specific compounds or formula (ID) whose G substituents are as defined above in Table G. In formula (ID), Q corresponds to R1 in formula (I).
Figure imgf000054_0001
Table D1 : This table provides 100 compounds D1-1 to D1-100 of formula (ID) wherein Q is 3-ethynyl- phenyl and G is as defined above in Table G. For example, compound D1-73 has the following structure:
Figure imgf000054_0002
Compound D1-73
Table D2: This table provides 100 compounds D2-1 to D2-100 of formula (ID) wherein Q is 3-phenyl and G is as defined above in Table G.
Table D3: This table provides 100 compounds D3-1 to D3-100 of formula (ID) wherein Q is 3- methylphenyl and G is as defined above in Table G.
Table D4: This table provides 100 compounds D4-1 to D4-100 of formula (ID) wherein Q is 3- chlorophenyl and G is as defined above in Table G.
Table D5: This table provides 100 compounds D5-1 to D5-100 of formula (ID) wherein Q is 3- cyclopropylphenyl and G is as defined above in Table G.
Table D6: This table provides 100 compounds D6-1 to D6-100 of formula (ID) wherein Q is 3- trifluoromethylphenyl and G is as defined above in Table G.
Table D7: This table provides 100 compounds D7-1 to D7-100 of formula (ID) wherein Q is 3- cyclopropyl-2-fluoro-phenyl and G is as defined above in Table G.
Table D8: This table provides 100 compounds D8-1 to D8-100 of formula (ID) wherein Q is 3-pyridyl and G is as defined above in Table G.
Table D9: This table provides 100 compounds D9-1 to D9-100 of formula (ID) wherein Q is 5-chloro-3- pyridyl and G is as defined above in Table G.
Table D10: This table provides 100 compounds D10-1 to E10-100 of formula (ID) wherein Q is 5-fluoro- 3-pyridyl and G is as defined above in Table G.
Table D11 : This table provides 100 compounds D11-1 to D11-100 of formula (ID) wherein Q is 5-methyl- 3-pyridyl and G is as defined above in Table G.
Table D12: This table provides 100 compounds D12-1 to D12-100 of formula (ID) wherein Q is 5-cyano- 3-pyridyl and G is as defined above in Table G. EXAMPLES
The Examples which follow serve to illustrate the invention.
The compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1 .5 ppm, 0.8 ppm or 0.2 ppm.
Compounds of Formula (I) may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile (including improved crop tolerance), improved physico-chemical properties, or increased biodegradability).
Throughout this description, temperatures are given in degrees Celsius (°C) and “mp.” means melting point. LC/MS means Liquid Chromatography Mass Spectrometry and the description of the apparatus and the method A is as follows:
Method A:
Spectra were recorded on a Mass Spectrometer 6410 Triple Quadruple Mass Spectrometer from Agilent Technologies equipped with an electrospray source (Positive and Negative Polarity Switch, Capillary (kV) 4.00, Scan Type MS2 Scan, Fragmentor (V) 100.00, Gas Temperature (°C) 350, Gas Flow (L/min) 11 , Nebulizer Gas (psi) 45, Mass range : 110 to 1000 Da) and an Agilent 1200 Series HPLC: DAD Wavelength range : 210 to 400 nm, Column : KINETEX EVO C18, Column length : 50 mm, Internal diameter of column : 4.6 mm, Particle Size : 2.6 pm, Column oven temperature : 40°C
Gradient conditions:
Solvent A: Water with 0.1 % formic acid : Acetonitrile : : 95 : 5 v/v
Solvent B: Acetonitrile with 0.1 % formic acid
Time (minutes) A (%) B (%) Flow rate (ml/min) 0 90 10 1.8
0.9 0 100 1.8
1.8 0 100 1.8
2.2 90 10 1.8
2.5 90 10 1.8
Where necessary, enantiomerically pure final compounds may be obtained from racemic materials as appropriate via standard physical separation techniques, such as reverse phase chiral chromatography, or through stereoselective synthetic techniques, eg, by using chiral starting materials.
Formulation Examples
Wettable powders a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 % sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate 6 % 10 % phenol polyethylene glycol ether 2 % (7-8 mol of ethylene oxide) highly dispersed silicic acid 5 % 10 % 10 %
Kaolin 62 % 27 %
The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.
Powders for dry seed treatment a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 %
Kaolin 65 % 40 %
Talcum 20 % The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.
Emulsifiable concentrate active ingredient [compound of formula (I)] 10 % octylphenol polyethylene glycol ether 3 %
(4-5 mol of ethylene oxide) calcium dodecylbenzenesulfonate 3 % castor oil polyglycol ether (35 mol of ethylene oxide) 4 %
Cyclohexanone 30 % xylene mixture 50 %
Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.
Dusts a) b) c)
Active ingredient [compound of formula (I)] 5 % 6 % 4 %
Talcum 95 %
Kaolin - 94 % mineral filler - - 96 %
Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.
Extruded granules
Active ingredient [compound of formula (I)] 15 % sodium lignosulfonate 2 % Carboxymethylcellulose 1 %
Kaolin 82 %
The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.
Coated granules
Active ingredient [compound of formula (I)] 8 % polyethylene glycol (mol. wt. 200) 3 %
Kaolin 89 %
The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.
Suspension concentrate active ingredient [compound of formula (I)] 40 % propylene glycol 10 % nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 %
Sodium lignosulfonate 10 %
Carboxymethylcellulose 1 % silicone oil (in the form of a 75 % emulsion in water) 1 %
Water 32 %
The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Flowable concentrate for seed treatment active ingredient [compound of formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 %
1 ,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % monoazo-pigment calcium salt 5 %
Silicone oil (in the form of a 75 % emulsion in water) 0.2 %
Water 45.3 %
The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.
Slow-Release Capsule Suspension 28 parts of a combination of the compound of formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1 .2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51 .6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1 ,6- diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.
The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns.
The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.
List of abbreviations aq. = aqueous
°C = degrees Celsius
DCM = dichloromethane
DMF = dimethylformamide
DMSO = dimethyl sulfoxide
DMSO-C/6 = deuterated dimethyl sulfoxide EtOAc = ethyl acetate equiv. = equivalent h = hour(s) M = molar min = minutes mp = melting point ppm = parts per million
RT = room temperature
Rt = retention time
LC/MS = Liquid Chromatography Mass Spectrometry (description of the apparatus and the methods used for LC/MS analysis are given above)
Preparation Examples
The following examples further illustrate, but do not limit, the invention. Those skilled in the art will promptly recognize appropriate variations from the procedures both as to reactants and as to reaction conditions and techniques.
1H NMR spectra are recorded at 400 MHz (megahertz) unless indicated otherwise and chemical shifts are recorded in ppm. The following abbreviations are used: s = singlet; br s = broad singlet; d = doublet; dd = double doublet; dt = double triplet; t = triplet, tt = triple triplet, q = quartet, quin = quintuplet, sept = septet; m = multiplet. Example 1 : Preparation of 3-(3-cyclopropylphenoxy)-N-[2-(2,4-dichlorophenyl)-2-fluoro- ethyllquinoline-4-carboxamide (compound 1 , Table T1)
Figure imgf000059_0001
Step A: Preparation of methyl 3-fluoroquinoline-4-carboxylate
Figure imgf000059_0002
To a suspension of 3-fluoroquinoline-4-carboxylic acid (0.2 g, 1.05 mmol, CAS [153880-32-1]) in ethyl acetate (4 mL) was added 2 drops of DMF followed by oxalyl chloride (0.10 mL, 1 .2 mmol) and the solution stirred at room temperature for 1 hour. The resulting mixture was quenched with methanol (0.08 mL, 2.1 mmol) and stirred 1 hour at room temperature. The reaction mixture was quenched carefully with a saturated NaHCOs aqueous solution and the resulting mixture was stirred at room temperature for 10 min. Water was added and the aqueous layer was extracted twice with ethyl acetate. The total combined organic layer was dried over magnesium sulfate, filtered and evaporated in vacuo to afford the methyl 3-fluoroquinoline-4-carboxylate which was used without further purification. LCMS (Method A): retention time 0.87 min, 206 (M+H)
1H NMR (CDCb, 400 MHz) 6 8.91 (d, 1 H), 8.0-8.3 (m, 2H), 7.6-7.9 (m, 2H), 4.12 (s, 3H)
Step B: Preparation of methyl 3-(3-cyclopropylphenoxy)quinoline-4-carboxylate
Figure imgf000059_0003
To a stirred solution of methyl 3-fluoroquinoline-4-carboxylate (0.1 g, 0.49 mmol) and 3- cyclopropylphenol (0.09 g, 0.63 mmol, CAS [28857-88-7]) in DMSO (1 mL) was added cesium carbonate (0.25 g, 0.73 mmol) and the reaction mass was allowed to stir at room temperature for 16h. The reaction mixture was quenched with water and extracted with ethyl acetate. The total combined organic fraction was dried over Na2SO4 and concentrated in vacuo. The crude product was purified by chromatography over silica gel, using cyclohexane/ethyl acetate as eluent system, to afford methyl 3-(3- cyclopropylphenoxy)quinoline-4-carboxylate. LCMS (Method A): retention time 1.15 min, 320 (M+H) 1H NMR (CDCl3, 400 MHz) δ 8.7-8.7 (m, 1H), 8.1-8.2 (m, 1H), 7.9-8.0 (m, 1H), 7.7-7.8 (m, 1H), 7.66 (dd, 1H), 7.24 (t, 1H), 6.8-6.9 (m, 3H), 3.98 (s, 3H), 1.8-2.0 (m, 1H), 0.9-1.0 (m, 2H), 0.71 (m, 2H) Step C: Preparation of 3-(3-cyclopropylphenoxy)quinoline-4-carboxylic acid
Figure imgf000060_0001
Methyl 3-(3-cyclopropylphenoxy)quinoline-4-carboxylate (0.16 g, 0.50 mmol) was dissolved in a mixture of tetrahydrofuran (3.7 mL) and water (1.2 mL). Lithium hydroxide hydrate (0.060 g, 1.4 mmol) was added and the resulting mixture was stirred for 2 days at RT. The solvent was evaporated in vacuo and the residue was taken up in water and ethyl acetate. The aqueous layer was extracted with ethyl acetate and the organic layer obtained discarded. Then, 2M HCl was added to the aqueous layer (pH 2 obtained) which was subsequently extracted twice with ethyl acetate. The total combined organic layer was dried over magnesium sulfate, filtered and concentrated in vacuo to afford 3-(3- cyclopropylphenoxy)quinoline-4-carboxylic acid. LCMS (Method A): retention time 0.91 min, 306 (M+H) 1H NMR (DMSO d6, 400 MHz) δ 14.1-14.2 (m, 1H), 8.71 (s, 1H), 8.11 (d, 1H), 7.9-8.0 (m, 1H), 7.7-7.9 (m, 2H), 7.2-7.3 (m, 1H), 6.87 (d, 1H), 6.7-6.8 (m, 2H), 1.93 (t, 1H), 0.9-1.0 (m, 2H), 0.6-0.7 (m, 2H) Step D: Preparation of 3-(3-cyclopropylphenoxy)-N-[2-(2,4-dichlorophenyl)-2-fluoro-ethyl]quinoline-4- carboxamide (Compound 1, Table T1)
Figure imgf000060_0002
A mixture of 3-(3-cyclopropylphenoxy)quinoline-4-carboxylic acid (0.05 g, 0.16 mmol), [2-(2,4- dichlorophenyl)-2-fluoro-ethyl]ammonium chloride (0.040 g, 0.163 mmol), triethylamine (0.12 mL, 0.818 mmol) and T3P (50 mass%) in ethyl acetate (0.29 mL, 0.49 mmol) was stirred in ethyl acetate (1 mL) at RT for one night. A further portion of [2-(2,4-dichlorophenyl)-2-fluoro-ethyl]ammonium chloride (0.040g, 0.163 mmol), T3P (50 mass%) in ethyl acetate (0.289 mL, 0.491 mmol) and triethylamine (0.10 mL, 0.818 mmol) were added and the resulting mixture was stirred 2 days more at room temperature. The reaction mixture was diluted with water and ethyl acetate. The aqueous layer was extracted three times with ethyl acetate. The total combined organic layer was dried over magnesium sulfate, filtered and concentrated in vacuo. The crude residue was purified via reverse phase high pressure liquid chromatography to afford 3-(3-cyclopropylphenoxy)-N-[2-(2,4-dichlorophenyl)-2-fluoro-ethyl]quinoline- 4-carboxamide. LCMS ( Method A): retention time 1.22 min, 495 (M+H) 1H NMR (CDCl3, 400 MHz) δ 8.67 (s, 1H), 8.12 (d, 1H), 7.93 (d, 1H), 7.72 (d, 1H), 7.6-7.6 (m, 1H), 7.4-7.5 (m, 1H), 7.38 (d, 1H), 7.2-7.3 (m, 1H), 7.17 (dd, 1H), 6.89 (d, 1H), 6.8-6.8 (m, 2H), 6.53 (br t, 1H), 5.8-6.0 (m, 1H), 4.1-4.3 (m, 1H), 3.8-4.0 (m, 1H), 1.88 (tt, 1H), 0.9-1.0 (m, 2H), 0.6-0.8 (m, 2H) Table T1: LCMS data and/or retention times (Rt) for compounds according to formula (I):
Figure imgf000061_0001
Biological Examples/Test Methods Alternaria solani (early blight of tomato): Tomato leaf disks are placed on water agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound is assessed 4 dpi (days post inoculation) as preventive fungicidal activity. The following compounds from Table T1 gave at least 80% control of Alternaria solani at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development: Table T1, Compound: 1.1 Botryotinia fuckeliana syn. Botrytis cinerea (Gray mould) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs. The following compounds from Table T1 gave at least 50% control of Botryotinia fuckeliana at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: Table T1, Compound: 1.1 Glomerella lagenarium syn Colletotrichum lagenarium (Anthracnose) Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620 nm. The following compounds from Table T1 gave at least 80% control of Glomerella lagenarium at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: Table T1, Compound: 1.1 Phaeosphaeria nodorum syn. Septoria nodorum (Glume blotch of wheat): Wheat leaf segments are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound is assessed 4 dpi (days after inoculation) as preventive fungicidal activity. The following compounds from Table T1 gave at least 80% control of Phaeosphaeria nodorum at 200 ppm when compared to untreated control under the same conditions, which sowed extensive disease development: Table T1, Compound: 1.1 Monographella nivalis syn. Microdochium nivale, Fusarium nivale (Snow mould, foot rot): Conidia of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620 nm. The following compounds from Table T1 gave at least 80% control of Monographella nivalis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development: Table T1, Compound: 1.1 Pyrenophora teres (Net blotch of barley) Barley leaf segments are placed on agar in multiwell plates (24-well format) and sprayed with test solutions. After drying, the leaf disks are inoculated with a spore suspension of the fungus. After appropriate incubation, the activity of a compound is assessed 4 dpi (days after inoculation) as preventive fungicidal activity.
The following compounds from Table T1 gave at least 80% control of Pyrenophora teres at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:
Table T1 , Compound: 1 .1
Sclerotinia sclerotiorum (Cottony rot, white mold)
Mycelial fragments of the fungus prepared from a fresh liquid culture were directly mixed into nutrient broth (PDB potato dextrose broth). A DMSO solution of the test compounds was placed into a microtiter plate (96-well format) and the nutrient broth containing the fungal spores was added to it. The test plates were incubated at 24 °C and the inhibition of growth was determined photometrically after 72 hrs at 620 nm.
The following compounds from Table T1 gave at least 80% control of Sclerotinia sclerotiorum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:
Table T1 , Compound: 1 .1

Claims

CLAIMS 1. A compound of Formula (I):
Figure imgf000064_0001
wherein: R1 is phenyl substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2-haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3- alkylsulfonyl, C1-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, and C3-C6-cycloalkyloxy; or R1 is phenyl optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, iso-propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or R1 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2-haloalkyl, C1- C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3-alkylsulfonyl, C1-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, and C3-C6-cycloalkyloxy; or R1 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is optionally substituted by 1 or 2 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, iso- propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; R2 and R3 are each independently selected from hydrogen, and C1-C4-alkyl; or R2 and R3, together with the carbon atom to which they are attached, form a C3-C6-cycloalkyl group; R4 and R5 are each independently selected from hydrogen, halogen, cyano, hydroxy, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, and C1-C4-haloalkoxy; or R4 and R5, together with the carbon atom to which they are attached, form an oxo or a C3-C6- cycloalkyl group; R6 is phenyl substituted by a single substituent selected from hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2-haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3- alkylsulfonyl, C1-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, and C3-C6-cycloalkyloxy; or R6 is phenyl optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, iso-propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; or R6 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is substituted by a single substituent selected from hydrogen, hydroxyl, halogen, mercapto, amino, cyano, C1-C4-alkyl, C1-C2- haloalkyl, C1-C4-alkoxy, C1-C3-alkylsulfanyl, C1-C3-alkylsulfinyl, C1-C3-alkylsulfonyl, C1-C2-haloalkoxy, C2-C3-alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C3-C6-cycloalkyl, and C3-C6-cycloalkyloxy; or R6 is a 5- or 6-membered monocyclic heteroaryl ring comprising 1, 2 or 3 heteroatoms each independently selected from N, O and S, and wherein the heteroaryl ring is optionally substituted by 1, 2 or 3 substituents each independently selected from hydroxyl, halogen, mercapto, amino, cyano, methyl, ethyl, propyl, isopropyl, vinyl, ethynyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, propyloxy, iso-propyloxy, tert-butoxy, propynoxy, methylsulfanyl, methylsulfonyl, difluoromethoxy, trifluoromethoxy, cyclopropyl, cyclobutyl, and cyclopropyloxy; Y1, Y2, Y3, and Y4 are each independently selected from N and CR7, with the proviso that at least two of Y1, Y2, Y3, and Y4 are selected from N and CH; R7 is independently selected from hydrogen, halogen, cyano, hydroxy, mercapto, C1-C3-alkyl, C1- C3-alkoxy, C1-C3-haloalkyl, C1-C3-haloalkoxy, C1-C3-alkylsulfonyl, C2-C3-alkynyl, and C3-C4-cycloalkyl; Z1 is N or CR8, wherein R8 is selected from hydrogen, halogen, cyano, hydroxy, C1-C3-alkyl, C1- C3-alkoxy, C1-C3-haloalkyl, C1-C3-haloalkoxy, C1-C3-alkylsulfonyl, C2-C3-alkenyl, C2-C3-alkynyl, and C3- C4-cycloalkyl; or an agrochemically acceptable salt, stereoisomer, enantiomer, and N-oxide of the compound of formula (I).
2. The compound according to claim 1, wherein the bicyclic moiety which comprises Y1, Y2, Y3, Y4, Z1 is selected from the groups (Ia) to (Iv):
Figure imgf000066_0001
where R7 is as defined in claim 1 ; m equals 0 or 1 ; and where the staggered lines represent the points of attachment of the bicyclic moiety to the remainder of the compound of formula (I).
3. The compound according to claim 1 or 2, wherein the bicyclic moiety which comprises Y1, Y2, Y3, Y4, Z1 is selected from (la), (lb), (Ic), (Id), (le), (Ig), (Ih) and (li), and m = 0.
4. The compound according to any one of claims 1 to 3, wherein R1 is selected from phenyl, pyridyl, pyrimidinyl and thienyl, wherein the phenyl, pyridyl, pyrimidinyl or thienyl is optionally substituted by 1 or 2 substituents each independently selected from methyl, chloro, fluoro, trifluoromethyl, methylsulfonyl, vinyl, ethynyl, propargyl, cyclopropyl, and cyclopropyloxy.
5. The compound according to any one of claims 1 to 4, wherein R1 is selected from phenyl, 3- cyclopropylphenyl, 3-pyridyl, 5-chloro-3-pyridyl, 5-methyl-3-pyridyl, and 5-cyano-3-pyridyl
6. The compound according to any one of claims 1 to 5, wherein R2 and R3 are each independently selected from hydrogen and methyl.
7. The compound according to any one of claims 1 to 6, wherein R2 and R3 are hydrogen.
8. The compound according to any one of claims 1 to 9, wherein R4 and R5 are each independently selected from hydrogen and fluoro; or R4 and R5 together with the carbon atom to which they are attached, form a cyclopropyl group.
9. The compound according to any one of claims 1 to 7, wherein R4 and R5 are each independently selected from hydrogen and fluoro.
10. The compound according to any one of claims 1 to 9, wherein R6 is selected from phenyl, 2- pyridyl, 3-pyridyl, and 4-pyridyl, wherein the phenyl, 2-pyridyl, 3-pyridyl or 4-pyridyl is optionally substituted by one or two substituents independently selected from chloro, fluoro, cyano, methyl, ethyl, trifluoromethyl, methoxy, methylsulfonyl, difluoro methoxy, vinyl, allyl, and ethynyl.
11 . The compound according to any one of claims 1 to 10, wherein R6 is selected from phenyl, 4- tolyl, 2,4-dichlorophenyl, 2-pyridyl, 2,4-difluorophenyl, 4-pyridyl, 2,4-dibromophenyl, 5-bromo-2-pyridyl, 2,4-dimethylphenyl, 3,5-dichloro-2-pyridyl, 2-chloro-4-fluorophenyl, 3-chloro-2-pyridyl, 2-chloro-4- bromophenyl, 3-chloro-5-methyl-2-pyridyl, 2-chloro-4-methylphenyl, 6-chloro-3-pyridyl, 2-chlorophenyl, and 4,6-dichloro-3-pyridyl.
12. The compound according to any one of claims 1 to 11 , when Y1, Y2, Y3, or Y4 is CR7, R7 is selected from hydrogen, fluoro, chloro, and methyl.
13. The compound according to any one of claims 1 to 12, wherein R7 is hydrogen.
14. The compound according to any one of claims 1 to 13, wherein Y1, Y2, Y3, and Y4 are CH.
15. The compound according to any one of claims 1 to 14, when Z1 is CR8, R8 is selected from hydrogen, fluoro, and chloro.
16. The compound according to claim 15, wherein R8 is hydrogen.
17. The compound according to any one of claims 1 to 16, wherein Y1, Y2, Y3, Y4, and Z1 are CH.
18. An agrochemical composition comprising a fungicidally effective amount of a compound according to any one of claims 1 to 17.
19. The composition according to claim 18, further comprising at least one additional active ingredient and/or at least one agrochemically-acceptable diluent or carrier.
20. A method of controlling or preventing infestation of useful plants by phytopathogenic microorganisms, wherein a fungicidally effective amount of a compound according to any of claims 1 to 18, or a composition comprising this compound as active ingredient, is applied to the plants, to parts thereof or the locus thereof.
21. Use of a compound according to any one of claims 1 to 17 as a fungicide.
PCT/EP2022/082566 2021-11-25 2022-11-21 Microbiocidal heterobiaryl amide derivatives WO2023094303A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21210606.6 2021-11-25
EP21210606 2021-11-25

Publications (1)

Publication Number Publication Date
WO2023094303A1 true WO2023094303A1 (en) 2023-06-01

Family

ID=78821526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2022/082566 WO2023094303A1 (en) 2021-11-25 2022-11-21 Microbiocidal heterobiaryl amide derivatives

Country Status (1)

Country Link
WO (1) WO2023094303A1 (en)

Citations (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639771A (en) 1984-10-31 1987-01-27 Kabushiki Kaisha Toshiba Image processing system
EP0357460A2 (en) 1988-09-02 1990-03-07 Sankyo Company Limited 13-Substituted milbemycin derivatives, their preparation and use
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
EP0382173A2 (en) 1989-02-07 1990-08-16 Meiji Seika Kaisha Ltd. PF 1022 substance, method of producing same and anthelmintic composition containing same
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0444964A1 (en) 1990-03-01 1991-09-04 Sankyo Company Limited Milbemycin ether derivatives, their preparation and their anthelmintic uses
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0503538A1 (en) 1991-03-08 1992-09-16 Meiji Seika Kaisha Ltd. Medicinal composition containing an anthelmintic cyclic depsipeptide
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
WO1993025543A2 (en) 1992-06-11 1993-12-23 Bayer Aktiengesellschaft Enniatines and enniatine derivates used to control endoparasites
EP0594291A1 (en) 1992-09-01 1994-04-27 Sankyo Company Limited Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
WO1994015944A1 (en) 1993-01-18 1994-07-21 Pfizer Limited New antiparasitic agents related to the milbemycins and avermectins
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
EP0626375A1 (en) 1993-05-26 1994-11-30 Bayer Ag Octacyclodepsipeptides having endoparasiticidal activity
WO1995019363A1 (en) 1994-01-14 1995-07-20 Pfizer Inc. Antiparasitic pyrrolobenzoxazine compounds
WO1995022552A1 (en) 1994-02-16 1995-08-24 Pfizer Limited Antiparasitic agents
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
US5478855A (en) 1992-04-28 1995-12-26 Yashima Chemical Industry Co., Ltd. 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline
WO1996011945A2 (en) 1994-10-18 1996-04-25 Bayer Aktiengesellschaft Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
WO1996015121A1 (en) 1994-11-10 1996-05-23 Bayer Aktiengesellschaft Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
DE19520936A1 (en) 1995-06-08 1996-12-12 Bayer Ag Ectoparasiticides means
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
WO2004072086A2 (en) 2003-02-14 2004-08-26 Pfizer Limited Antiparasitic terpene alkaloids
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
WO2008110313A1 (en) 2007-03-12 2008-09-18 Bayer Cropscience Ag Phenoxyphenylamidines as fungicides
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2012136604A1 (en) 2011-04-07 2012-10-11 Nimblegen Systems Gmbh Diarylsulphid backbone containing photolabile protecting groups
WO2014006945A1 (en) 2012-07-04 2014-01-09 アグロカネショウ株式会社 2-aminonicotinic acid ester derivative and bactericide containing same as active ingredient
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
WO2015155075A1 (en) 2014-04-11 2015-10-15 Syngenta Participations Ag Fungicidal n'-[2-methyl-6-[2-alkoxy-ethoxy]-3-pyridyl]-n-alkyl-formamidine derivatives for use in agriculture
WO2016156085A1 (en) 2015-03-27 2016-10-06 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2016156290A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
WO2016202742A1 (en) 2015-06-15 2016-12-22 Bayer Cropscience Aktiengesellschaft Halogen-substituted phenoxyphenylamidines and the use thereof as fungicides
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017029179A1 (en) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Triazole derivatives, intermediates thereof and their use as fungicides
WO2017055469A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017093348A1 (en) 2015-12-02 2017-06-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017153380A1 (en) 2016-03-10 2017-09-14 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018153707A1 (en) 2017-02-22 2018-08-30 Basf Se Crystalline forms of a strobilurin type compound for combating phytopathogenic fungi
WO2018158365A1 (en) 2017-03-03 2018-09-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018202428A1 (en) 2017-05-02 2018-11-08 Basf Se Fungicidal mixture comprising substituted 3-phenyl-5-(trifluoromethyl)-1,2,4-oxadiazoles
WO2018228896A1 (en) 2017-06-14 2018-12-20 Syngenta Participations Ag Fungicidal compositions
WO2019110427A1 (en) 2017-12-04 2019-06-13 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
WO2020109391A1 (en) 2018-11-28 2020-06-04 Bayer Aktiengesellschaft Pyridazine (thio)amides as fungicidal compounds
WO2021160470A1 (en) 2020-02-13 2021-08-19 Basf Se Preparation of aromatic carbonyl compounds by catalytic oxidation with molecular oxygen
WO2021233861A1 (en) 2020-05-19 2021-11-25 Bayer Aktiengesellschaft Azabicyclic(thio)amides as fungicidal compounds
WO2021249995A1 (en) 2020-06-10 2021-12-16 Bayer Aktiengesellschaft Azabicyclyl-substituted heterocycles as fungicides

Patent Citations (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639771A (en) 1984-10-31 1987-01-27 Kabushiki Kaisha Toshiba Image processing system
EP0451878A1 (en) 1985-01-18 1991-10-16 Plant Genetic Systems, N.V. Modifying plants by genetic engineering to combat or control insects
EP0357460A2 (en) 1988-09-02 1990-03-07 Sankyo Company Limited 13-Substituted milbemycin derivatives, their preparation and use
EP0367474A1 (en) 1988-11-01 1990-05-09 Mycogen Corporation Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0374753A2 (en) 1988-12-19 1990-06-27 American Cyanamid Company Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines
US5015630A (en) 1989-01-19 1991-05-14 Merck & Co., Inc. 5-oxime avermectin derivatives
EP0382173A2 (en) 1989-02-07 1990-08-16 Meiji Seika Kaisha Ltd. PF 1022 substance, method of producing same and anthelmintic composition containing same
WO1990013651A1 (en) 1989-05-09 1990-11-15 Imperial Chemical Industries Plc Bacterial genes
EP0401979A2 (en) 1989-05-18 1990-12-12 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
EP0427529A1 (en) 1989-11-07 1991-05-15 Pioneer Hi-Bred International, Inc. Larvicidal lectins and plant insect resistance based thereon
EP0444964A1 (en) 1990-03-01 1991-09-04 Sankyo Company Limited Milbemycin ether derivatives, their preparation and their anthelmintic uses
EP0503538A1 (en) 1991-03-08 1992-09-16 Meiji Seika Kaisha Ltd. Medicinal composition containing an anthelmintic cyclic depsipeptide
WO1993007278A1 (en) 1991-10-04 1993-04-15 Ciba-Geigy Ag Synthetic dna sequence having enhanced insecticidal activity in maize
WO1993019053A1 (en) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
US5478855A (en) 1992-04-28 1995-12-26 Yashima Chemical Industry Co., Ltd. 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline
WO1993025543A2 (en) 1992-06-11 1993-12-23 Bayer Aktiengesellschaft Enniatines and enniatine derivates used to control endoparasites
EP0594291A1 (en) 1992-09-01 1994-04-27 Sankyo Company Limited Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
WO1994015944A1 (en) 1993-01-18 1994-07-21 Pfizer Limited New antiparasitic agents related to the milbemycins and avermectins
WO1994019334A1 (en) 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
EP0626375A1 (en) 1993-05-26 1994-11-30 Bayer Ag Octacyclodepsipeptides having endoparasiticidal activity
WO1995019363A1 (en) 1994-01-14 1995-07-20 Pfizer Inc. Antiparasitic pyrrolobenzoxazine compounds
WO1995022552A1 (en) 1994-02-16 1995-08-24 Pfizer Limited Antiparasitic agents
WO1995034656A1 (en) 1994-06-10 1995-12-21 Ciba-Geigy Ag Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests
WO1996011945A2 (en) 1994-10-18 1996-04-25 Bayer Aktiengesellschaft Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
WO1996015121A1 (en) 1994-11-10 1996-05-23 Bayer Aktiengesellschaft Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
DE19520936A1 (en) 1995-06-08 1996-12-12 Bayer Ag Ectoparasiticides means
WO1997033890A1 (en) 1996-03-11 1997-09-18 Novartis Ag Pyrimidin-4-one derivatives as pesticide
WO2002015701A2 (en) 2000-08-25 2002-02-28 Syngenta Participations Ag Bacillus thuringiensis crystal protein hybrids
WO2003018810A2 (en) 2001-08-31 2003-03-06 Syngenta Participations Ag Modified cry3a toxins and nucleic acid sequences coding therefor
WO2003052073A2 (en) 2001-12-17 2003-06-26 Syngenta Participations Ag Novel corn event
US6919298B2 (en) 2002-04-04 2005-07-19 Valent Biosciences Corporation Enhanced herbicide composition
WO2004072086A2 (en) 2003-02-14 2004-08-26 Pfizer Limited Antiparasitic terpene alkaloids
WO2008110313A1 (en) 2007-03-12 2008-09-18 Bayer Cropscience Ag Phenoxyphenylamidines as fungicides
WO2011138281A2 (en) 2010-05-06 2011-11-10 Bayer Cropscience Ag Process for the preparation of dithiine tetracarboxydiimides
WO2012136604A1 (en) 2011-04-07 2012-10-11 Nimblegen Systems Gmbh Diarylsulphid backbone containing photolabile protecting groups
WO2014006945A1 (en) 2012-07-04 2014-01-09 アグロカネショウ株式会社 2-aminonicotinic acid ester derivative and bactericide containing same as active ingredient
WO2014095675A1 (en) 2012-12-19 2014-06-26 Bayer Cropscience Ag Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
WO2015155075A1 (en) 2014-04-11 2015-10-15 Syngenta Participations Ag Fungicidal n'-[2-methyl-6-[2-alkoxy-ethoxy]-3-pyridyl]-n-alkyl-formamidine derivatives for use in agriculture
WO2016156085A1 (en) 2015-03-27 2016-10-06 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2016156290A1 (en) 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
WO2016202742A1 (en) 2015-06-15 2016-12-22 Bayer Cropscience Aktiengesellschaft Halogen-substituted phenoxyphenylamidines and the use thereof as fungicides
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2017029179A1 (en) 2015-08-14 2017-02-23 Bayer Cropscience Aktiengesellschaft Triazole derivatives, intermediates thereof and their use as fungicides
WO2017055469A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017055473A1 (en) 2015-10-02 2017-04-06 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017093348A1 (en) 2015-12-02 2017-06-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017118689A1 (en) 2016-01-08 2017-07-13 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017153380A1 (en) 2016-03-10 2017-09-14 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
WO2017220485A1 (en) 2016-06-21 2017-12-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018065414A1 (en) 2016-10-06 2018-04-12 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018153707A1 (en) 2017-02-22 2018-08-30 Basf Se Crystalline forms of a strobilurin type compound for combating phytopathogenic fungi
WO2018158365A1 (en) 2017-03-03 2018-09-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018202428A1 (en) 2017-05-02 2018-11-08 Basf Se Fungicidal mixture comprising substituted 3-phenyl-5-(trifluoromethyl)-1,2,4-oxadiazoles
WO2018228896A1 (en) 2017-06-14 2018-12-20 Syngenta Participations Ag Fungicidal compositions
WO2019110427A1 (en) 2017-12-04 2019-06-13 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
WO2020109391A1 (en) 2018-11-28 2020-06-04 Bayer Aktiengesellschaft Pyridazine (thio)amides as fungicidal compounds
WO2021160470A1 (en) 2020-02-13 2021-08-19 Basf Se Preparation of aromatic carbonyl compounds by catalytic oxidation with molecular oxygen
WO2021233861A1 (en) 2020-05-19 2021-11-25 Bayer Aktiengesellschaft Azabicyclic(thio)amides as fungicidal compounds
WO2021249995A1 (en) 2020-06-10 2021-12-16 Bayer Aktiengesellschaft Azabicyclyl-substituted heterocycles as fungicides

Non-Patent Citations (32)

* Cited by examiner, † Cited by third party
Title
"Bioorg. Med. Chem. Lett.", vol. 18, 2008, pages: 5115
"Modern Nucleophilic Aromatic Substitution", 2013, WILEY-VCH
"The Pesticide Manual - A World Compendium", THE BRITISH CROP PROTECTION COUNCIL, article "The Pesticide Manual"
"The Pesticide Manual", 2009, BRITISH CROP PROTECTION COUNCIL
A. WOOD, COMPENDIUM OF PESTICIDE COMMON NAMES, 1995
BULLETIN DE LA SOCIETE CHIMIQUE DE FRANCE, vol. 8, 1972, pages 3198 - 202
CAN. J. CHEM., vol. 56, 1978, pages 1273
CAS , no. 153880-32-1
CHEM. SOC. REV., vol. 38, 2009, pages 606
CHEM. SOC. REV., vol. 40, 2011, pages 5084
EUR. J. ORG. CHEM., vol. 18, 2011, pages 3353
FANG, W ET AL., ORG. LETT., vol. 15, 2013, pages 3678 - 705
FRIIS, D ET AL., ORG. LETT., vol. 16, 2014, pages 4296 - 4299
J. AM. CHEM. SOC., vol. 79, 1957, pages 1502
J. CHEM. SOC., 1950, pages 395
J. CHEM. SOC., 1951, pages 2992
J. CHEM. SOC., 1953, pages 3914
J. ORG. CHEM., vol. 69, 2004, pages 1565 - 1570
J. ORG. CHEM., vol. 74, 2009, pages 7951
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 41, 2004, pages 987 - 989
JOURNAL OF ORGANIC CHEMISTRY, vol. 84, 2019, pages 7395 - 7404
ORG. LETT., vol. 5, 2003, pages 1381
ORGANIC LETTERS, vol. 11, 2009, pages 1321 - 1324
RSC ADVANCES, vol. 4, 2014, pages 48177 - 48190
SYNTH. COMMUN., vol. 12, 1982, pages 989 - 993
TET. LETT., 1977, pages 4171 - 4174
TET. LETT., 2006, pages 5767 - 5769
TETRAHEDRON LETT, vol. 39, 1998, pages 2933
TETRAHEDRON LETT, vol. 44, 2003, pages 3863
TETRAHEDRON LETT., vol. 39, 1998, pages 2933
TETRAHEDRON LETT., vol. 44, 2003, pages 3863
TETRAHEDRON LETT., vol. 53, 2012, pages 5318

Similar Documents

Publication Publication Date Title
AU2019389778B2 (en) Microbiocidal thiazole derivatives
EP3887361A1 (en) Microbiocidal 2-acylamino-thiazole-4-carboxamide derivatives
EP3947371B1 (en) Microbiocidal thiazole derivatives
US20230192678A1 (en) Microbiocidal derivatives
EP4326710A1 (en) Microbiocidal quinoline/quinoxaline isoquinoline derivatives
WO2022207665A1 (en) Microbiocidal quinoline/quinoxaline benzothiazine derivatives
WO2021204822A1 (en) Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
EP3976622B1 (en) Microbiocidal derivatives
EP3976601B1 (en) Microbiocidal derivatives
WO2023094303A1 (en) Microbiocidal heterobiaryl amide derivatives
WO2023148206A1 (en) Microbiocidal n-amide derivatives
WO2023094304A1 (en) Microbiocidal heterobiaryl amide derivatives
EP4313949A1 (en) Microbiocidal isonicotinic amide derivatives
WO2023118011A1 (en) Microbiocidal aza-heterobiaryl derivatives
WO2023089049A2 (en) Microbiocidal isonicotinic amide derivatives
WO2023166067A1 (en) Microbiocidal pyridazinone amide derivatives
WO2023110871A1 (en) Microbiocidal pyrazole derivatives
EP3976610A1 (en) Microbiocidal derivatives
WO2024068947A1 (en) Microbiocidal pyrazole derivatives
EP4132926A1 (en) Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
WO2021204855A1 (en) Microbiocidal quinoline dihydropyrrolopyrazine derivatives
WO2023111215A1 (en) Microbiocidal pyridine-substituted benzothiazine derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22821382

Country of ref document: EP

Kind code of ref document: A1